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“The important thing in science is not so much to obtain new facts as to discover new 
ways of thinking about them.” 
- Sir William Lawrence Bragg 
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Abstract 
The present study investigates the mechanism of Amphotropic Murine Leukemia Virus (A-
MLV) internalization in a variety of cells. Using dextran, a fluid-phase marker, it was demonstrated 
that macropinocytosis is active in the representative cell lines and inhibition of A-MLV 
internalization was evident in cells treated with macropinocytosis inhibitors, amiloride and EIPA. In 
addition, overexpression of PiT-2 receptor resulted in higher A-MLV intake and PiT-2 localization 
was found not to be in the lipid raft of the plasma membrane where caveolae-dependent entry 
occurs.  
Host defense peptides (HDPs) were used to assess the interference with A-MLV 
internalization. LL-37, bovine lactoferricin, bovine lactoferrin and 1018 peptides contributed to the 
increase in the A-MLV uptake which was inhibited by amiloride and EIPA.  
HDPs binding properties towards certain glycosaminoglycans were demonstrated using both 
affinity chromatography and capillary electrophoresis frontal analysis methods. Affinity 
chromatography studies revealed the importance of the charge and the structural conformation of 
the peptides with respect to their affinities to heparan- and chondroitin sulfate. This is the first study 
where capillary electrophoresis frontal analysis is used for the study of high-molecular-weight 
cationic peptides (nisin A, bovine lactoferricin, bovine lactoferrin)-polyelectrolyte (chondroitin 
sulfate) interactions based on the established use of this method in determination of low-molecular-
weight ligands-polyelectrolyte interactions. However, affinity constants for peptides and 
chondroitin sulfate could not be derived, except for nisin A, due to the difficulties posed by the 
peptides during the analysis. 
 
 In concluding remarks, these findings suggest A-MLV entry in a variety of cells via 
macropinocytosis and that the use of affinity chromatography and capillary electrophoresis as 
analytical tools is important in order to establish quantitative peptide-activity relationships.  
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1. Aim of the study and study objectives 
 
The aim of the present research is to establish better understanding of a molecular phenomena 
using the knowledge from both biological and physiochemical perspectives. The biological 
approach of the experimental analysis aims towards the Amphotropic Murine Leukemia Virus (A-
MLV) use of macropinocytosis as a potential entry pathway in mouse fibroblast and human 
epithelial cell lines. The biochemistry part tends to elucidate some of the host defense peptide 
binding properties towards certain proteoglycans. The chemistry part aims to assess peptide-
glycosaminoglycans interactions in terms of affinity binding using affinity chromatography and 
quantify the binding affinities from more analytical perspective using capillary electrophoreses 
frontal analysis and if possible isothermal titration calorimetry. All in all the data obtained from the 
biological and chemical investigations would give an insight into the interference of the host 
defense peptides in A-MLV internalization by macropinocytosis.   
1.1. Study objectives 
 
Viruses have established different ways to successfully infect a wide range of host cells, despite 
their simple composition. Most viral infections are initiated by virus attachment to different host 
cell surface receptors, followed by endocytic internalization which may involve clathrin mediated 
endocytosis and clathrin-independent pathways such as macropinocytosis and caveolar/lipid raft-
mediated endocytosis. The knowledge gained from the study of viral entry mechanism can be 
implemented in early termination of viral infections in medical practise. In addition since some 
viruses are used in molecular medicine as a gene delivery vectors in gene therapy studies, the 
information on a specific viral entry mechanism can contribute to a successful gene delivery. 
Murine Leukemia Virus (MLV) is used as a viral vector for gene transfer in animal models. This 
study presents an investigation of the involvement of macropinocytosis in A-MVL internalization 
for the first time.  
The objective of the molecular biology part of the study is: 
-to elucidate the mechanism of amphotropic murine leukemia virus (A-MLV) internalization in 
different cell models.  
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To establish equilibrium constants for molecules interacting with each other, different 
methodological approaches have been established. Models to predict these different constants 
appear to be useful in the pharmaceutical industry to screen large number of compounds in a short 
time. Using affinity chromatography, binding affinities of 95 diverse drugs and drug like 
compounds to human serum albumin have been determined and a quantitative structure-activity 
relationship model to predict the binding affinities to human serum albumin of new compounds on 
the basis of their structure has been derived (Colmenarejo, Alvarez-Pedraglio et al. 2001). In 
addition, the retention times of polycyclic aromatic compounds measured by HPLC have been used 
for direct determination of the distribution coefficient for these polycyclic aromatic compounds 
between organic carbon and water (Koc) (Jonassen, Nielsen et al. 2003). Inspired by such 
approaches, capillary electrophoresis and isothermal titration calorimetry techniques can be used for 
determination of binding constants between different peptides and glycosaminoglycans 
(polyelectrolytes). Capillary electrophoresis studies on peptides interaction with heparan- and 
chondroitin sulfate polyelectrolytes are going to reveal essential knowledge about peptide structural 
requirements for the different degree of A-MLV interaction. This knowledge can be implemented 
into AMLV internalization mechanism. Moreover, depending on the data obtained, a correlation 
between the binding constants and the retention times derived from affinity chromatography 
experiments could be further investigated. 
The objective of the chemistry part of the study is: 
- to quantify peptide affinities towards heparan- and chondroitin sulfate using affinity 
chromatography, capillary electrophoresis and if possible isothermal titration calorimetry.  
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2. Molecular biology and chemistry chapter specification 
 
This report presents an interdisciplinary study integrating molecular biology and chemistry. 
Therefore specific chapters are written in regards to the molecular biology part and other with 
regards to the chemistry part of the study. Chapters 3.1-3.5 give an introduction to the murine 
leukemia viruses, virus entry mechanisms, in addition to proteoglycans and glycosaminoglycans 
structure and function, a brief summary of the structures and function of all of the peptides used 
throughout the study and the peptide mode of antiviral activity, respectively.  Chapters 3.6, 3.7 and 
3.8 outline the chemistry background in terms of a comprehension of electrostatic interactions 
between peptides and glycosaminoglycans followed by a brief introduction to affinity 
chromatography and capillary electrophoresis methods.  However, the knowledge represented in 
Chapters, 3.3, 3.4 and 3.6 is essential for the overall understanding of the main idea of the present 
study. Regardless of the background specified for each part, the results are discussed in one chapter 
following the sequence of their presentation in the results section. The project sums up the 
interconnection of the both fields of study in an overall discussion followed by a conclusion of the 
present research. 
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3. Introduction 
 
The following chapters introduce general information to aid the understanding of the particular 
virus of this study, amphotropic murine leukemia virus (A-MLV). In addition, the entry pathways 
exploited by viruses for successful infection of host cells are introduced.   
 
3.1  Murine Leukemia Viruses  
 
In the early 1950s, a virus that caused cancer in mice was identified by Ludwig Gross, an 
Polish-American virologist (Gross 1951). After his discovery, a lot of work was undertaken to map 
the genome of Murine Leukemia Virus (MLV). MLVs are gammaretroviruses, and vectors derived 
from them are used as viral vectors for gene transfer in animal models. Retroviruses are able to 
successfully deliver a specific genomes and integrate the same into the genome of the infected cells 
thus passing the genetic information to the progeny (Karavanas, Marin et al. 1998). Murine 
leukemia virus is an enveloped virus, spherical in shape and 80-100 nm in diameter. Based on the 
viral envelope protein (Env) recognition of different receptors on the cells membrane, MLVs have 
been divided into five subgroups (Katane, Takao et al. 2002); ecotropic (E-MLV), amphotropic (A-
MLV), polytropic, xenotropic MLV and 10A1 murine leukemia virus (Hunter and Swanstrom 
1990). Ecotropic and amphotropic are the most essential MLV-based retroviral vectors, infecting 
murine cells only and murine cells together with other vertebrate species, respectively (Hartley and 
Rowe 1976).  
Murine Leukemia Virus has a single stranded, positive sense RNA molecule (ss+RNA) 
extending about 8 kbp. The genome consists of structural genes that encode the viral proteins 
needed for its replication. The structural genes are gag (a group-specific antigen) encoding the viral 
matrix (MA), capsid (CA) and nucleoproteins (NC); pol, region encoding the viral enzymes reverse 
transcriptase (RT), integrase (IN) and protease (PRO) and env encoding surface glycoprotein (SU) 
and transmembrane (TM) protein involved in specific receptor binding and envelope-cell membrane 
fusion, respectively (Karavanas, Marin et al. 1998) (Fig. 1). 
 8 
 
 
Figure 1. Structure and genomic organization of complex gammaretrovirus. Murine leukemia virion has 
only one RNA genome, contrary to the generalization depicted on the figure. The envelope proteins, the 
surface glycoprotein [SU] and the transmembrane protein [TM] from the env gene, the core proteins; matrix 
[MA],capsid [CA], nucleocapsid [NC] from the gag gene and reverse transcriptase [RT],integrase [IN] and 
protease [PRO] from pol gene are indicated (Silverman, Nguyen et al. 2010). 
MLVs life cycle involves primary recognition and attachment to the receptor proteins of the 
host cells by the viral surface subunit (SU) containing the receptor binding domain. This is followed 
by capsid translocation to the cytoplasm where reverse transcription of the RNA genome takes 
place. The proviral DNA is then transported into the cell nucleus where it gets integrated into the 
cellular DNA, enabling transcription of the viral proteins. The genomic RNA together with gag and 
pol products are encapsidated and the viral particles bud off the host cell, mature and are then ready 
to  infect new cells and undergo the same process of replication (Karavanas, Marin et al. 1998). 
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3.2 Viral entry mechanisms 
 
Viruses have established different ways to successfully infect a wide range of host cells, despite 
their simple composition. The majority of viruses initially bind to a generalized receptor 
(attachment factor) on the host cell surface during their internalization process and then interact 
with more specialized host cell receptor, which enables membrane fusion or internalization of the 
viral genomic material (Kalia and Jameel 2009). The receptor specificity defines the preference for 
specific endocytic pathways. 
Endocytic internalization processes exploited by viruses are clathrin-mediated endocytosis 
(CME) and clathrin-independent endocytosis which includes macropinocytosis and caveolar/lipid 
raft-mediated endocytosis (Fig. 2) (Mercer, Schelhaas et al. 2010). The formation of endocytic 
vesicles and vacuoles by either pathway involves recruitment of a large number of cellular factors. 
Clathrin mediated viral entry is the most utilized internalization pathway by which viruses are 
internalized in the cells quite rapidly. This process is involved in the uptake of essential nutrients 
for the cell such as transferrin, growth factors and antigens (Ghigo 2010). Clathrin mediated 
endocytosis involves viral association to clathrin coated pits, after which the virus is internalized 
into clathrin coated vesicles of about 100 nm (Ghigo 2010). Vesicular Stomatitis Virus (VSV) and  
Influenza A are some of the viruses that use this pathway to infect mammalian cells (Mercer, 
Schelhaas et al. 2010). Cholesterol, lipid rafts and rather complicated signaling pathways are 
characteristics of the caveolar/raft dependent entry pathway. The mechanism of action is via 
caveolae, specialized lipid rafts, by which albumin in addition to many bacterial toxins is 
internalized in the cells. The best-studied viruses up to date, which use this internalization pathway, 
are viruses from the polyomavirus family (i.e. non-enveloped simian virus 40) (Mercer, Schelhaas 
et al. 2010). Some of the mentioned pathways are activated by signal transduction cascades 
stimulated by viral binding to the host cell surface which aids endocytosis. Moreover, individual 
viruses show the advantage of being able to enter a host cell using more than one specialized 
pathway such as the Herpes simplex virus (Spear 2004; Nicola, Hou et al. 2005; Clement, Tiwari et 
al. 2006) and poliovirus (Brandenburg, Lee et al. 2007). Different viruses and their primary 
endocytic pathways are listed in table 1. 
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Table 1.  Different entry mechanisms for mammalian viruses.  
 
 
Figure 2. Scheme of endocytic pathways used by viruses as their internalization route. Shown here are 
the general pathways used by viruses. Vesicular stomatitis virus (VSV), human immunodeficiency virus 1 
(HIV-1) and influenza virus are typical examples of viruses that use clathrin mediated endocytosis  for their 
internalization; simian virus 40 (SV40) uses caveolar type endocytosis; mimivirus enters the cells by 
phagocytosis, pathway restricted to specialized phagocytic cells; fusion entry by herpes simplex virus 1 
(HSV-1); macropinocytotic entry by vaccine virus (VV), HSV-1, HIV-1, adenovirus-3 (Ad3). Illustration 
edited and reprinted with permission under Creative Commons Attribution License from (Ghigo, 
Kartenbeck et al. 2008)  
   Virus family                  Virus                  Primary Endocytic pathways    Reference  
Rhabdo (ssRNA-)  Vesicular Stomatitis Virus 
(VSV)/ enveloped 
 Clathrin Mediated 
 Endocytosis (CME)  
(Cureton, Massol et al. 2009) 
Adeno (dsDNA)          Adenovirus 2 and 5  
/ nonenveloped                               
Clathrin Mediated 
 Endocytosis (CME) 
(Medina-Kauwe 2003; Meier 
and Greber 2004) 
Myxo (ssRNA-) Influenza A/enveloped CME /Novel Pathway (Sieczkarski and Whittaker 
2002; Rust, Lakadamyali et 
al. 2004) 
Pox (dsDNA) Vaccinia virus/enveloped Macropinocytosis (Mercer and Helenius 2008; 
Sandgren, Wilkinson et al. 
2010; Schmidt, Bleck et al. 
2011) 
Adeno (dsDNA) Adenovirus 3/enveloped Macropinocytosis (Amstutz, Gastaldelli 
et al. 2008) 
Herpes(dsDNA) Herpes simplex virus 1 
(HSV1) /enveloped 
Macropinocytosis/ 
Phagocytosis 
(Nicola, McEvoy et al. 
2003) 
Retro (ssRNA+) 
 
HIV-1/enveloped 
 
Macropinocytosis 
 
(Marechal, Prevost et al. 
2001) 
Polyoma (dsDNA) Simian Virus 40                  
/ nonenveloped 
Caveolin 1/Lipid raft (Anderson, Chen et al. 
1996) 
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The dependence of interaction with host cell receptors for viral entry is an essential part of the 
infectious cycle. Murine Leukemia Viruses, as all of the retroviruses, recognize specific receptors. 
The ecotropic (E-MLV) type, infects only murine cells and uses the amino acid transporter mCAT1 
as a receptor (Leverett, Farrell et al. 1998). The amphotropic virus (A-MLV) has a wide infectious 
mammalian host range including human, and PiT-2 (Ram1), a sodium-dependent phosphate (NaPi) 
symporter has been identified as its receptor (Miller and Miller 1994; Miller and Wolgamot 1997). 
The polytropic and xenotropic MLV use Xpr1(Syg1) as their receptor (Nethe, Berkhout et al. 2005). 
Entry of retroviruses occurs via membrane fusion and the ecotropic murine leukemia virus exploits 
a pH-dependent membrane fusion. Despite the E-MLV pH-dependent entry, studies have shown 
pH-independent entry for the amphotropic MLV (McClure, Sommerfelt et al. 1990). Different 
internalization pathways utilized by A-MLV have been illustrated in other studies.  
Amphotropic murine leukemia viruses, as mentioned before, utilize PiT-2 as a specific receptor 
to infect mammalian cells ranging from murine to human cells. PiT-2 is a multiple membrane 
spanning protein with size of about 71 kDa (Chien, Foster et al. 1997), exposing five of its ten 
transmembrane domains to the exterior of the cell (Fig. 3). The first extracellular domain (ECD1) is 
the crucial site for A-MLV recognition and attachment (Feldman, Farrell et al. 2004). PiT-2 has a 
wide distribution in mammalian tissues exhibiting different mRNA levels in different cell types 
(Bottger, Hede et al. 2006). The transcription of PiT-2 has been shown to be affected by the 
extracellular phosphate concentration, whereby low phosphate concentration contributes to an 
increase of PiT-2 mRNA levels (Chien, Foster et al. 1997). In such case, the level of susceptibility 
to A-MLV infection increases (Salaun, Gyan et al. 2002).  5 
 
Figure 3. Distribution of human PiT-2 receptor in A31 (h) PiT-2 fibroblasts (right) and topological 
model of human PiT-2 (left) (Virkki, Biber et al. 2007). 
 12 
 
The endocytic viral entry pathway of A-MLV has been investigated in a few studies. Upon NH4Cl 
treatment, A-MLV could still infect NIH 3T3 cells referring to a pH-independent infection route 
exploited by A-MLV (McClure, Sommerfelt et al. 1990). Later A-MLV entry was shown to be via 
CME pathway also employed by E-MLV (Katen, Januszeski et al. 2001). Beer and coworkers have 
proposed caveolar dependent internalization (Beer, Andersen et al. 2005; Beer, Pedersen et al. 
2005; Beer and Pedersen 2006). Recently, through a series of experiments the entry route of A-
MLV has been elaborated. A-MLV entry via caveolar-independent pathway has been demonstrated 
as caveolin knockout cells showed higher susceptibility to A-MLV than the wild type cells (Moneva 
2010). Based on electron microscope images, the virus is often found on the cell surface closely 
localized to the ruffled parts of the cell membrane and virus particles can be found within large 
intracellular vacuoles in these areas. In addition, immunoflourescence studies did not show co-
localization of YFP A-MLV with the labeled caveolin-1 (Moneva, Vilhardt 2011–unpublished 
data). These experiments contradict the published caveolin dependent internalization of A-MLV 
(Beer, Andersen et al. 2005; Beer, Pedersen et al. 2005; Beer and Pedersen 2006) and suggest an 
alternative pathway, which will be investigated in the present study, i.e. macropinocytosis.  
 
3.2.1 Macropinocytosis 
 
Many viruses are able to utilize several internalization pathways and some of them, despite their 
specific entry route, are able to also accomplish successful infection via fluid phase uptake (Mercer 
and Helenius 2009; Ghigo 2010). Macropinocytosis is an endocytic pathway used by cells for 
ingestion of large volumes of extracellular fluids. It is a constitutive process in dendritic cells as 
well as in macrophages and neutrophils and can be induced by specific stimuli in other non-immune 
cell types. The uptake of fluid requires formation of large endocytic vacuoles, called 
macropinosomes (0.5-10 µm), created by actin cytoskeleton remodeling and reorganization of the 
cell membrane (Doherty and McMahon 2009; Mercer and Helenius 2009). Macropinosomes are 
formed when the membrane ruffles extending from the cell surface collapse and fuse with each 
other or with the cell membrane, forming fluid-filled cavities (Fig. 4). The size of macropinosomes 
together with their later acidification and intersection with sorting vesicles, makes macropinocytosis 
a possible route of internalization for a wide variety of viruses (Hewlett, Prescott et al. 1994).  
Macropinocytosis can be growth factor induced, i.e. by epidermal growth factor (EGF) and platelet-
derived growth factor (PDGF) (Kerr and Teasdale 2009). In addition, some viruses can induce 
membrane ruffling and promote viral internalization together with the surrounding fluid (Mercer, 
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Schelhaas et al. 2010). Viruses reported to make use of macropinocytosis as their direct and/or 
indirect way of internalization are vaccinia virus (VV) (Sandgren, Wilkinson et al. 2010), human 
adenovirus-3 (Ad3) (Kalin, Amstutz et al. 2010), herpes simplex virus-1 (HSV-1), Kaposi’s 
sarcoma-associated herpes virus, echovirus-1and HIV-1 (Mercer, Schelhaas et al. 2010). 
 
Figure 4.  Macropinocytic plasma membrane ruffling visualized by scanning electron microscopy and 
formation of macropinosomes. Membrane ruffling induced by the activation of actin and microfilaments 
connected to the plasma membrane. The membrane protrusions take the form of lamellipodia like 
protrusions, circular cup-shaped extensions (circular ruffles) and large membrane extrusions (blebs). a) 
Lamellipodia ruffles in A431 cells. b) Circular ruffling in macrophages. c) Vaccinia virus mature virions 
induced blebbing in HeLa cells (Mercer and Helenius 2009). 
Macropinocytosis unlike endocytosis and phagocytosis is not regulated by cargo/receptor 
interaction. The cellular components required for macropinocytosis stimulation are complex, 
interconnected and vary in different cell types. Various small GTPases of the Rho family of 
GTPases are involved in the membrane movement and actin cytoskeleton rearrangement leading to 
global elevation of actin-mediated cell membrane ruffling and increase in macropinosome 
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formation (Ridley, Paterson et al. 1992; Kerr and Teasdale 2009). Many lipids and proteins which 
regulate actin polymerization and membrane trafficking are modified by the GTP-bound forms of 
these proteins. To exemplify, Rac1 stimulates actin polymerization by activating p21-activated 
kinase Pak1 which phosphorylates a number of kinases modulating actin cytoskeleton and further 
phosphorylates CtBP1/BARS, a protein that mediates macropinosome closure (Dharmawardhane, 
Schurmann et al. 2000). Cdc42 and RhoA GTPases stimulate actin polymerization through 
activation of different complexes (Swanson 2008). However, the detailed mechanisms and 
participation of these proteins in the signaling pathways is still debated. Macropinocytosis is 
susceptible to inhibitors of Na
+
/H
+
 exchange, amiloride and the more selective analogue 
ethylisopropylamiloride (EIPA). These chemicals are often used to assess the macropinocytic 
process (Koivusalo, Welch et al. 2010).  
In addition to pathogen internalization, macropinocytosis together with the other endocytic 
pathways have been implicated in the uptake of bioactive molecules such as nucleic acids, peptides 
and therapeutic agents into the cells (Jones 2007; Kerr and Teasdale 2009). 
3.3  Proteoglycans and glycosaminoglycans  
 
Proteoglycans (PGs) are macromolecules that have a core protein containing at least one 
covalently bound glycosaminoglycan (GAG) chain.  The diverse function and structure that they 
exploit, depends on their cellular localization which is determined by the core protein. 
Proteoglycans can occur intracellularly, at the cell surface or in the extracellular matrix (Kjellen and 
Lindahl 1991) and have important role in regulation of molecule trafficking in the cells as well as 
chemical signaling between the cells. They serve as a binding site for various signaling molecules 
that are sequestered within secretory vesicles or follow other interactions. Some proteoglycans are 
integral part of the plasma membrane with their core protein located across the lipid bilayer. The 
role of most of these proteoglycans is to act as co-receptors. The intracellular membrane-spinning 
core protein part (i.e. the cytoplasmic domain) is believed to interact with the actin cytoskeleton and 
many signaling molecules (Fig. 6). Cell surface proteoglycans contain unbranched sulfated (except 
hyaluronic acid) and carboxylated polysaccharide chains composed of disaccharide repeating units, 
one of which is always an amino sugar (N-acetylglucosamine (Fig. 5) or N-acetylgalactosamine) 
and can affect cell adhesion and control cell proliferation. The second unit is usually uronic acid 
(glucuronic or iduronic) (Fig. 5). Glycosaminoglycans are the most anionic molecules produced by 
animal cells. Based on the sugar linkage and the number and location of sulfo-groups on the 
carbohydrate backbone, GAGs are divided into four groups, namely 1) hyaluronan, 2) chondroitin 
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sulfate and dermatan sulfate, 3) heparin/heparan sulfate and 4) keratan sulfate (Fig. 5) (Carney and 
Muir 1988; Kjellen and Lindahl 1991; Bernfield, Gotte et al. 1999; Liu and Thorp 2002). The 
differences between the groups are the repeating units found in each polymer. Glucoronic acid 
(GlcA), iduronic acid (IdoA), galactose (Gal) linked to a glucosamine (GlcN) or galactosamine 
(GalN) in keratan sulfate, are some of the possible saccharides that contribute to the heterogeneity 
of the glycosaminoglycans. The number of GAG chains (generally attached to serine residues) 
varies from 1 to 100 (Carney and Muir 1988; Kjellen and Lindahl 1991) and each chain can consist 
of as many as 200 disaccharide units, but are typically less than half that size (Alberts, Johnson et 
al. 2008). Despite the importance of proteoglycans in a variety of cellular functions, microbial 
pathogens also benefit from recognition of some of the glycosaminoglycans (Ruoslahti 1989; 
Bernfield, Gotte et al. 1999). More than two decades ago the inhibitory activity of exogenously 
added sulfated polysaccharides against various enveloped viruses, HSV-1, CMV, VSV and HIV-1 
has been reported (Vaheri 1964; Baba, Snoeck et al. 1988). Heparan- and chondroitin sulfate are 
two of the most well studied GAGs that assist viral infections, both being investigated and 
discussed in the present study. 
 
Figure 5. Glycosaminoglycans structures. The structures of the four different groups of 
glycosaminoglycans are shown, edited from (Volpi, Maccari et al. 2008; Malavaki, Theocharis et al. 2011). 
Each glycosaminoglycan is composed of a number of repeating disaccharide units, one of which is always an 
amino sugar (N-acetylglucosamine or N-acetylgalactosamine) and the other is usually uronic acid 
(glucuronic or iduronic). 
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Heparan sulfate (HS) is present on the cell surface as heparan sulfate proteoglycans (HSPGs), 
consisting of core protein containing heparan sulfate side chains. It is a linear carbohydrate polymer 
composed of repeating disaccharide units (Fig. 5), sulfated at various positions (Zhu, Li et al. 2011). 
Due to complex enzymatic modifications during heparan sulfate biosynthesis, long heterogeneous 
glycosaminoglycan chains are formed. These chains are found in two major families of 
proteoglycans, the syndecans (Fig. 6) and glypicans (Bernfield, Gotte et al. 1999). Heparan sulfate 
proteoglycans bind many proteins by the interaction of heparan sulfate polysaccharide side chains, 
which bear sulfate groups that carry negative charges under physiological pH, and the basic 
residues on the protein surfaces (Liu and Thorp 2002). The biological function of heparan sulfate 
chains is diverse. Despite binding various proteins from biological importance, heparan sulfate can 
enhance peptide diffusion, establish concentration gradient as well as modulate receptor-ligand 
interactions (Bernfield, Gotte et al. 1999). These roles have been realized by studying cellular 
responses of heparan sulfate biosynthesis defective cells. Adsorption of many viruses is mediated 
by an interaction between viral surface molecules (HS-binding domains) and the carbohydrate 
moieties (heparin/HS) of the proteoglycans (Mercer, Schelhaas et al. 2010) through the S-regions 
(sulphated regions) of the carbohydrates. By this, heparan sulfate acts as a co-receptor mediating 
host cell attachment followed by binding to other specific receptors by which viruses enter into the 
host cell. Cytomegalovirus, Herpes simplex viruses I and II as well as HIV are some of the viruses 
that bind to cell surface proteoglycans, though this binding often is insufficient in triggering a 
robust viral infection. Even though the co-receptor role of heparan sulfate has received much 
attention, the mechanism by which heparan sulfate acts is not always clear (Bernfield, Gotte et al. 
1999). 
Chondroitin sulfate (CS) is the most abundant cartilage glycosaminoglycan. It is a 
heteropolymer consisting of repeating units of glucuronic acid and N-acetyl galactosamine (Fig. 5). 
Chondroitin sulfate units can be sulfated at the C-4 or C-6 position, however heterogeneous 
structures containing sulfate groups at both positions have been determined (Carney and Muir 
1988). Based on the position of the sulfate groups, there are five types of chondroitin sulfates; i.e. 
chondroitin-4-sulfate (CS-A), chondroitin sulfate B (dermatan sulfate), chondroitin- 6-sulfate (CS-
C), chondroitin-2, 6-sulfate (CS-D) and chondroitin-4,6-sulfate (CS-E) (Bergefall, Trybala et al. 
2005). Chondroitin sulfate as most of the GAGs, is involved in cell adhesion and growth, maintains 
the extracellular matrix (ECM) integrity, assists in signal transduction and aids pathogen attachment 
to the cell surface and internalization (Carney and Muir 1988). 
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Figure 6. Schematic diagram of the cell surface proteoglycan syndecan and glycosaminoglycan chain 
in syndecan (Lodish H 2000). Syndecan core proteins contain transmembrane domain, cytoplasmic domain 
and extracellular domain. The extracellular domain carries both heparan- and chondroitin sulfate side chains. 
The glycosaminoglycans side chains are covalently linked to the core protein via the serine residue 
(Ruoslahti 1989; Liu and Thorp 2002). 
Chondroitin sulfate serves as an initial receptor for several human and animal viruses and as such is 
a known target for design of novel drugs for antiviral intervention. In absence of heparan sulfate 
chains, cell surface chondroitin sulfate supports herpes simplex virus (HSV) infection (Banfield, 
Leduc et al. 1995). In addition, the vaccinia virus envelope protein D8L, binds to chondroitin 
sulfate on cells during virus infection (Hsiao, Chung et al. 1999). This binding is relevant for the 
viral fusion and successful internalization in the host cells (Chung, Hsiao et al. 1998; Hsiao, Chung 
et al. 1999). Dengue virus (DENV) is another virus which interaction with chondroitin sulfate-E 
(CS-E) is an important step in the early stages of the viral infection (Kato, Era et al. 2010). 
3.4  Host defense peptides  
 
Host defense peptides (HDPs), play an important role in the innate immune system in variety of 
organisms, ranging from simple prokaryotes, plants, amphibians and mammals including humans. 
They are considered as a potential future antibiotics based on their properties and application. To 
date, many have been investigated for their specific activities against bacteria, fungi and viruses. 
The antimicrobial agents are relatively short consisting of up to 100 amino acids, are positively 
charged, amphiliphic and exhibit diversity based on their structural properties (Jenssen, Hamill et al. 
2006). One of the properties that make them good antimicrobial agents is the presence of arginine 
(pKa=12) and lysine (pKa=10.4) residues which are the most basic amino acids, being protonated at 
physiological pH and therefore in living systems react with many negatively charged molecules. 
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Host defense peptides have been reported to act in various ways to effectively protect against many 
bacteria, fungal and viral infections. They act directly by interacting with the pathogen membranes 
in several modes, creating increased membrane permeability and cell death in bacteria. In addition, 
they can interact with viral or host cell membrane receptor molecules and occupy the binding sites 
important for virus internalization (Jenssen, Hamill et al. 2006). They can also stimulate an immune 
system response by up-regulation of various effector molecules within animal cells (Brown and 
Hancock 2006). Regarding their physiochemical properties, even though peptides primary 
structures may share many homologues sequences, the secondary structures can be very different. 
The predominant conformations of peptides are the amphiphatic α-helices, β-sheets and loop 
structures (Fig. 7). The following section gives a brief overview of the structures and antimicrobial 
activities of the host defense peptides and proteins used in this study, namely, LL-37, synthetic host 
defense peptide 1018, NisinA, bovine lactoferrin and bovine lactoferricin.   
 
  
Figure 7. Five structural conformations of antimicrobial peptides. A) mixed structure; B) looped 
structure; C) β-sheet structure; D) multiple β-sheets; E) α-helix structure (Jenssen, Hamill et al. 2006).  
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3.4.1 Human cathelicidin LL-37 
 
Cathelicidins are a diverse group of vertebrate antimicrobial peptides. They consist of highly 
conserved N-terminal segment (the cathelin domain) which is proteolitically cleaved by serine 
proteases to generate an active peptide. In human only one cathelicidin has been identified: LL-37 
(Fig. 8), cleaved from the C-terminal end of the human CAP18 protein (hCAP18). LL-37 is an 
important secretion protein, most abundant in the granules of neutrophils but can be found in other 
cell types such as keratinocytes, epithelial cells and monocytes (Yang, Biragyn et al. 2004).  
Studies have demonstrated that LL-37 is an important component of the innate immune system, 
acting against a wide range of pathogens. Besides the direct antimicrobial activity, LL-37 is a 
multifunctional peptide being involved in dendritic cell differentiation, mast cell degranulation, 
wound healing and immune activation (Gordon, Huang et al. 2005). The antiviral inhibitory activity 
has been reported against Herpes simplex virus type 1 (HSV1) and several types of adenoviruses as 
well as HIV (Yasin, Pang et al. 2000; Gordon, Huang et al. 2005). In addition, concentration 
dependent inhibition of vaccinia virus has been observed in tissue culture cells, preincubated with 
human (LL-37) and murine (CRAMP) cathelicidins (Howell, Jones et al. 2004). 
 
Figure 8. Structure of LL-37.  LL-37 has molecular weight of 4493.3Da with an isoeletric point (pI) of 
11.1 and net charge of 6 at pH 7. The acidic residues are shown in red, basic in blue, and hydrophobic in 
white (Yasin, Pang et al. 2000; Yang, Biragyn et al. 2004). 
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3.4.2 1018  
 
In the development of more potent class of host defense peptides, IDR-1018 (referred to as 
1018), a 12 amino acids (Fig. 9) containing peptide had been generated by solid phase peptide 
synthesis methods (Wieczorek, Jenssen et al. 2010). 1018 as a promising antimicrobial candidate 
shares amino acid composition similarity with another peptide with established antibacterial 
activity, Bac2A (RLARIVVIRVAR) (Wu and Hancock 1999; Wu and Hancock 1999). Circular 
dichroism data has shown that 1018 can adopt different conformations in different environments 
and is unstructured in water surroundings.  The structure-function relationships of the peptide 1018 
have been characterized on Gram-positive and Gram-negative bacteria (Wieczorek, Jenssen et al. 
2010). However, no antiviral activity of 1018 has been established yet.  
 
Figure 9. Representative structure of the synthetic innate defense peptide, 1018. The structure shown is 
the most dominant confirmation of 1018. Peptide 1018 consists of 12 amino acids, which sequence is shown 
and carries net positive charge of 4 at physiological pH (Wieczorek, Jenssen et al. 2010). 
 
3.4.3 Nisin A 
 
Nisin A is one of the oldest known peptide lantibiotics* (see glossary) produced by the Gram-
positive bacterium Lactococcus lactis. It consists of 34 amino acid residues some of which are 
unusual; dehydrobutyrine (Dhb), dehydroalanine (Dha), lanthionine and β-methyl lanthionine 
(Gross and Morell 1971). The thio-ether bridges between the lanthionine form five ring-like 
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structures (Fig. 10). The N–terminal of the polypeptide chain contains a number of hydrophobic 
residues whereas the C-terminal is more hydrophilic and of a basic character due to the presence of 
the positively charged side chains of lysine and histidine. There are no amino acids with negatively 
charged side chains, thus nisin has a net positive charge at neutral pH (Rollema, Kuipers et al. 
1995).The antimicrobial properties of nisin A have been well established and therefore it has a great 
implication in the food industry as a preservative (Delves-Broughton, Blackburn et al. 1996). Five 
natural nisin variants have been described; nisin A, nisin Z, nisin Q and two forms of nisin U 
(Lubelski, Rink et al. 2008). 
 
Figure 10. Structure of Nisin. A) Five rings formed by thio-ether bridges are shown in yellow B) 
The primary structure of nisin as described by Gross. ABA = aminobutyric acid (lanthionine);DHA = 
dehydroalanine; DHB = dehydrobutyrine (Gross and Morell 1971; Liu and Hansen 1990; Christianson 
2006). 
 
3.4.4 Lactoferrin  
 
Lactoferrin (LF) is a multifunctional, Mr 80 kDa glycoprotein, that was originally discovered as 
an iron-binding protein present in milk (Sørensen 1939). Later on the protein was found to be 
distributed in other external secretions such as, tears, saliva, nasal secretions, secreted by mucosal 
epithelia and neutrophils granules (Baker 2005). The protein is comprised of a 691 for human- and 
689 for bovine lactoferrin, amino acids containing polypeptide chain, folded in two globular folds 
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connected with α-helix (Fig. 11) (Adlerova 2008). The N-terminal region of lactoferrin is highly 
basic due to the high proportion of arginine and lysine residues (van Berkel, Geerts et al. 1997). The 
antimicrobial activity of lactoferrin has been intensively studied and many conserved regions 
relevant for the specific activity have been underlined. Lactoferrin is thought to play a role in the 
innate host defense system and in many other biological activities and immune reactions (Adlerova 
2008). 
The ability to inhibit growth of wide range of Gram-positive, Gram-negative bacteria, fungi and 
parasites have been reported (Chierici 2001). Also, lactoferrin exhibits antiviral effects on various 
viruses; bovine herpes virus 1, herpes simplex virus 1, influenza A virus, HIV as well as 
adenovirus, enterovirus and rotavirus (Berkhout, van Wamel et al. 2002; Seganti, Di Biase et al. 
2004; Jenssen, Sandvik et al. 2008; Pietrantoni, Dofrelli et al. 2010). The antiviral property of 
lactoferrin has been shown to be due to the ability to bind different DNA and RNA viruses and 
moreover interact with cell surface glycosaminoglycans, thus preventing viral internalization at 
early stage (Ward, Paz et al. 2005). Such inhibition mechanism has been proposed for herpes 
simplex virus type 1 and cytomegalovirus (Andersen, Osbakk et al. 2001; Andersen, Jenssen et al. 
2004; Marchetti, Trybala et al. 2004). However, the exact mechanism of the viral inhibitory effect 
still remains controversial.  
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Figure 11. Bovine Lactoferrin structure and amino acid composition. A) Ribbon diagram of crystal 
structure of bovine lactoferrin, B) Colored regions correspond to the positively charged regions-blue, 
negatively charged regions-red and neutral regions-white C) Table showing the amino acid composition 
comparing bovine and human lactoferrin. The homology between the bovine and human lactoferrin is 69% 
(Rey, Woloshuk et al. 1990; Pierce, Colavizza et al. 1991; Jenssen and Hancock 2009).  
3.4.5 Lactoferricin  
 
Lactoferricin (Lfcin) is a potent antimicrobial peptide, generated by pepsin digestion of the 
native protein, lactoferrin. It is derived from the N-terminal region of both human and bovine 
lactoferrin molecules, resulting in human (LfcinH) and bovine (LfcinB) lactoferricin, respectively 
(Tomita, Bellamy et al. 1991). Bovine lactoferricin consists of 25 amino acids, most of which are 
with cationic character giving a net positive charge (+8) at physiological pH. The 19
th
 and 36
th
  
residues are linked by a disulfide bridge contributing to the distorted antiparallel β-sheet 
confirmation (Fig. 12) (Hwang, Zhou et al. 1998). Studies have attributed to the antimicrobial 
properties of bovine lactoferricin with respect to Gram-positive, Gram-negative bacteria, fungi and 
viruses. Bovine lactoferricin antiviral properties have been described against adenovirus (Di Biase, 
Pietrantoni et al. 2003) by interaction with the cell surface proteoglycans and herpes simplex virus 
(Andersen, Jenssen et al. 2004; Marr, Jenssen et al. 2009) in a similar fashion. 
 
Figure 12. Bovine lactoferricin structure.  A) Secondary structure of LfcinB in solution, disulfide bridge 
shown in yellow, tryptophan (Trp) residues shown in blue. B) Illustration of charge distribution of the 
LfcinB residues; positively charged-blue, negatively charged-red, neutral regions –white. (Gifford, Hunter et 
al. 2005) 
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3.5  Mode of antiviral activity  
 
A number of host defense peptides have been evaluated to elucidate their antiviral mode of 
action on various classes of viruses, i.e. enveloped, nonenveloped, DNA or RNA viruses. The 
antiviral activity of these molecules appears to be closely related with the viral adsorption and early 
entry route or is presumably due to peptides interaction with the viral envelope (Jenssen, Hamill et 
al. 2006). This chapter summarizes the possible modes of antiviral action of peptides with focus on 
the viral entry attenuation by heparan- and chondroitin sulfate interactions. It gives a brief overview 
of the interactions of peptides with specific host cell receptors and viral membranes. However, 
some of the host defense peptides elucidate their antiviral activities targeting host cell antiviral 
mechanisms such as viral gene/protein expression and can also block cell-to-cell spread of viruses 
(Jenssen, Hamill et al. 2006). Some of the well known peptides and their antiviral activity against 
several viruses are listed in table 2.  
Table 2. Example of antiviral peptides  
Peptide Structure Virus Proposed antiviral mechanism Reference 
LL-37 α-helix HSV Weak viral inactivation (Yasin, Pang et 
al. 2000) 
Lactoferricin β-sheet HCMV 
 
HIV 
HSV 
Interferes with virus-cell  
interaction 
Unknown 
Blocks heparan sulfate in 
addition to another effect 
(Andersen, 
Osbakk et al. 
2001; 
Andersen, 
Jenssen et al. 
2003; Jenssen, 
Andersen et al. 
2004) 
Mellitin α-helix HSV 
*Junin virus 
Cellular target 
Cellular target 
(Albiol 
Matanic and 
Castilla 2004) 
Defensin β-sheet HSV 
 
VSV 
HIV 
Adenovirus 
HSV membrane/glycoprotein 
interaction 
Inactivated viral particles 
Cellular target 
Unknown 
(Nakashima, 
Yamamoto et 
al. 1993; 
Bastian and 
Schafer 2001; 
Cole, Hong et 
al. 2002; Sinha, 
Cheshenko et 
al. 2003; Yasin, 
Wang et al. 
2004) 
* see glossary of terms  
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1) Viral entry attenuation by heparan sulfate (HS)/chondroitin sulfate (CS) interaction 
 
As mentioned in one of the previous chapters, glycosaminoglycan chains are found in virtually 
all tissues and play an important part in many biological interactions. Containing a high degree of 
sulfated groups that makes them highly polyanionic species, glycosaminoglycans bind to small 
cations, proteins, enzymes, in addition to various pathogens, including viruses (Jenssen, Hamill et 
al. 2006). Heparan sulfate has been reported to be involved in the viral attachment and thus 
occupying heparan sulfate chains can reduce viral infection (Shieh, WuDunn et al. 1992). However 
the importance of heparan sulfate in viral infections differs with different viruses. Recombinant 
cells lacking both heparan- and chondroitin sulfate exhibit reduction of herpes simplex virus 
infection when compared with wild type cells expressing both GAGs (Mardberg, Trybala et al. 
2002). When cells expressing heparan- and chondroitin sulfate have been treated with heparitinase 
and chondroitinase-ABC, which remove cell surface heparan- and chondroitin sulfate, respectively, 
the role of these GAGs in HIV-1 infection have been elucidated. Heparan sulfate and to a higher 
extent cell-associated chondroitin sulfate greatly facilitate effective entry of HIV-1, but 
demonstrated minor effect on HIV-1 attachment to the host cells (Argyris, Acheampong et al. 
2003). Addition of soluble chondroitin types A, B and C showed strong interference with 
adsorption of HSV-1 in a dose-dependent manner (Banfield, Leduc et al. 1995). From the 
information above, the hypothesis that a peptide that interacts with heparan sulfate and chondroitin 
sulfate should be able to block viral infection is inevitable (Fig. 13).  
 
Figure 13. Illustration showing an enveloped virus attenuation entry by the interaction of peptides 
with heparan- (blue) and chondroitin sulfate (yellow) side chains found on the cell surface. 
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LL-37 interaction with different glycosaminoglycans, namely dermatan sulfate and chondroitin 
sulfate E, has been demonstrated (Schmidtchen, Frick et al. 2002). The knowledge of the specific 
domains that are responsible for the observed interaction between peptides and glycosaminoglycans 
are of a great importance. Therefore many studies have put an effort to evaluate the structural 
requirements for such interactions. The entire domain in bovine lactoferricin (Shimazaki, Tazume et 
al. 1998) and G1RRRS6 and R28KVR31 in human lactoferricin (36% sequence similarity with bovine 
lactoferricin) have been identified as the glycosaminoglycans binding domains (Mann, Romm et al. 
1994). The overall charge of the peptide together with the distribution of the positively charged 
amino acids in the secondary structure of the peptide, contribute to the antiviral activity observed. 
This has been elucidated in studies where various bovine and human lactoferricin analogs and 
synthetic peptides have been used to investigate how the affinity of the peptides towards heparan-
and chondroitin sulfate relates with the observed HSV-1 and HSV-2 antiviral activity (Jenssen, 
Andersen et al. 2004-1; Jenssen, Andersen et al. 2004-2).  
 
2) Blocking of viral entry by peptide interaction with specific host cell receptors and cellular 
membrane 
 
Virus infection can be inhibited by engaging viral host cell receptors. That is the case with the 
18-residue peptide, T22 that inhibits HIV-1 infection through its specific binding to a chemokine 
receptor, CXCR4, which serves as a coreceptor for HIV-1 entry (Tamamura, Xu et al. 1998). 
Another peptide, an eight residues cyclic D,L-α-peptide has been shown to prevent pH decrease in 
endocytic vesicles, thus arresting adenovirus particles from entry (Horne, Wiethoff et al. 2005). 
 
3) Blocking of viral entry by viral envelope proteins and viral glycoproteins interaction 
 
Inhibition of the viral infection can be achieved by peptides that target the viral envelope 
proteins. A number of synthesized peptides have been tested for inhibitory activity against 
enveloped West Nile virus. The inhibitory activity of the most potent peptide has been 
demonstrated to be due to the ability to bind to the West Nile envelope protein E and therefore 
negatively affect the viral infection (Bai, Town et al. 2007). Moreover, the antimicrobial peptide 
indolicidin causes a direct inactivation of HIV-1 in a temperature-sensitive way consistent with a 
membrane mediated antiviral mechanism (Robinson, McDougall et al. 1998). Blocking of viral 
entry by peptide interaction with viral glycoproteins have been illustrated by the interaction of 
retrocyclin 2 peptide with HSV-2 glycoprotein B (Yasin, Wang et al. 2004). 
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Due to the importance and consideration of peptide interaction with glycosaminoglycans, the 
following chapter illustrates the nature of this interaction. Moreover in the determination of 
equilibrium constants for the peptide-glycosaminoglycan interactions, a knowledge concerning the 
nature of the interaction when building a binding model for the same is required. The following 
chapter points out the characteristics behind peptide/protein-glycosaminoglycan interactions. In 
addition, in order for one to validate the strength of the interactions between peptides and 
glycosaminoglycans, various chemical methods are applied. An introduction to two methods that 
are used in the present study follows after, namely fast protein liquid chromatography (FPLC) and 
capillary electrophoresis (CE. Isothermal titration calorimetry is the third method considered for 
establishing binding constants between peptides and glycosaminoglycans but due to the limited 
time and materials for the ITC experiments, no relevant data was established. However an 
introduction for the principles behind ITC is given in Appendix 1.  
3.6  Peptide-Glycosaminoglycan interactions  
 
Complexation between various proteins and their ligands is a chemically reversible equilibrium 
process. Enzymes and other proteins that act as “host” molecules recognize and bind various small 
“guest” molecules with high affinity and well-defined stoichiometry. However, in other systems 
proteins recognize molecules that have larger effective radii in the range of 10-100 nm and can bind 
many proteins reversing the host-guest relationship (Seyrek and Dubin 2010). Such molecules are 
polyelectrolytes, species that carry sufficient ionizable groups within their repeating units, resulting 
in charged chains with dissociable counterions in polar solvents like water. DNA, RNA and 
glycosaminoglycans are examples of biological macromolecules with a polyelectrolyte character 
(Seyrek and Dubin 2010). Peptide/protein and polyelectrolyte interactions require deeper 
understanding from both biochemical and physiochemical perspectives. The nature and the 
structural requirements of the peptide/protein-polyelectrolyte interactions have been described 
(Lohman and Mascotti 1992; Ziegler and Seelig 2004; Goncalves, Kitas et al. 2006; Seyrek and 
Dubin 2010). Peptide/protein-polyelectrolyte complexes arise from the reaction between the 
flexible polyion and the positively charged domains of the peptide or the protein (Hattori, Bat-Aldar 
et al. 2005). The overall binding is governed by electrostatic interactions, which have been well 
described in the literature (Record, Lohman et al. 1976; Manning 1978; Seyrek and Dubin 2010). 
One of the first studies describing a protein–polyelectrolyte interaction system was reported in a 
1976 study where the thermodynamics of protein-DNA interaction was illustrated, explaining 
protein-DNA interaction as an ion exchange reaction (Record, Anderson et al. 1978). In solution, 
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counterions such as sodium ions (Na
+
) bind to the negatively charged groups of the polyelectrolyte 
to minimize the repulsive forces within the polyelectrolyte as demonstrated by NMR studies with 
DNA and hyaluronic acid (Anderson, Record et al. 1978; Sicinska, Adams et al. 1993). When 
protein is added to the solution, the positively charged groups (Arg
+
, Lys
+
) of the protein displace 
the sodium counterions, contributing to the entropy of the system (Fig. 14).  This study suggests 
that the protein binding to polyelectrolytes will decrease with increasing NaCl concentrations and is 
illustrated by the following equation: (Lohman and Mascotti 1992).  
 Protein  polyelectrolyte (m sites + Na+ unoccupied sites) ⇌ Protein----polyelectrolyte  m Na+      Eq. 1 
where, m is the number of Na
+ 
released upon protein-polyelectrolyte binding.  
Thus, in thermodynamic studies the free energy (ΔG) of protein binding to polyelectrolyte is 
derived from the Na
+ 
release from the polyelectrolyte chain to the surrounding which is entropically 
favorable and is called the “polyelectrolyte effect” (Record, Lohman et al. 1976).  However, the 
contributions of hydrogen bonding and hydrophobic interactions are not to be excluded (Lohman 
and Mascotti 1992). 
 
Figure 14. Illustration of an electrostatic interaction between a peptide and a polyelectrolyte (DNA, 
GAG). The use of different salt concentrations in analysis of protein-glycosaminoglycan interaction is an 
indication about the contribution of the polyelectrolyte effect to the interaction.  
Besides the nature of the interaction, the specificity, regarding specific domains needed for the 
interaction to occur have also been discussed. The first study to look at the structural requirements 
of protein-glycosaminoglycans interaction was reported in 1989 by Cardin and Weintraub (Cardin 
and Weintraub 1989). Protein consensus* (see glossary) sequences binding to glycosaminoglycan 
chains have been proposed from that study indicating that proteins and peptides interact specifically 
with glycosaminoglycans (Hileman, Fromm et al. 1998). For the characterization of peptide/protein-
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glycosaminoglycan interactions, studies have used affinity chromatography, equilibrium dialysis, 
affinity electrophoresis, fluorescence, NMR and isothermal titration calorimetry (ITC) techniques.  
 
3.7  Fast protein liquid chromatography and affinity chromatography  
 
In the present study in order to investigate whether peptides activity in the peptide-viral assay is 
correlated with glycosaminoglycan binding capacity, fast protein liquid chromatography operating 
at affinity mode is used.  
Fast protein liquid chromatography (FPLC) is a form of automated liquid chromatography that 
provides full range of chromatography modes. It is similar to the high performance liquid 
chromatography (HPLC) system but differs in the pressure applied to the stationary phase and flow 
volume. FPLC has been originally developed for protein purification due to the high loading 
capacity, fast flow rates, availability of different stationary phases and ability to operate in various 
modes such as; ion exchange, hydrophobic interactions, reverse phase, gel filtration and affinity. In 
addition in FPLC columns, proteins can be loaded in large volumes and biocompatible buffers can 
be applied (Madadlou, O'Sullivan et al. 2011). 
  Since all biological processes happen as a result of molecules interacting with one another, 
affinity chromatography exploits these interactions, separates biomolecules on the basis of a 
reversible interaction between the biomolecules and their specific ligand, and further separates 
molecules based on their structure or biological function. Affinity chromatography separates 
molecules of interest (peptides, proteins, lectins etc.) based on a reversible interaction between the 
molecule and a specific ligand coupled to a chromatographic matrix. The affinity matrix should be 
insoluble, chemically inert towards the sample and should contain suitable chemical group for 
ligand binding. Common commercially available matrices are agarose beads, cellulose and 
polyacrylamide  (Urh, Simpson et al. 2009). Further on, for successful affinity analysis, a 
biospecific ligand should be covalently coupled with the chromatographic matrix and should retain 
its specific binding affinity towards the target molecule. The ligand-target molecule interactions can 
be: enzyme with inhibitors, or cofactors; antibody with antigens or viruses and hormones and 
vitamin with receptors or carrier proteins (Urh, Simpson et al. 2009). The interactions between the 
ligand and its target molecule can be electrostatic, hydrophobic, or mediated by hydrogen bonding 
or van der Walls’ forces. When the target molecule is eluted, these interactions are reversed by 
application of a competitive ligand in the elution buffer or by changing the pH environment, the 
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ionic strength or polarity. The elution is performed by application of a linear gradient (continuous 
elution) which includes a stepwise increase of salt concentration to wash out the more strongly 
bound ligand.  
Various cationic peptides, including bovine and human lactoferrin, lactoferricin and different 
lactoferricin derivatives, have previously been investigated for their antiviral activity towards 
herpes simplex virus  in correlation to  heparan- and chondroitin sulfate binding capacity, using 
affinity chromatography (Jenssen, Andersen et al. 2004; Jenssen, Andersen et al. 2004-2; Jenssen, 
Gutteberg et al. 2005; Jenssen, Gutteberg et al. 2006).  From the affinity studies one can deduce the 
peptide structural requirements for heparan- and chondroitin sulfate binding that will help design 
more potent antiviral peptides or in other cases gain information for peptide interferences in viral 
studies in general. 
 
Figure 15. Fast protein liquid chromatography (FPLC) instrumental set up and NaCl gradient elution 
of a peptide on heparan sulfate column. Heparan sulfate chains are linked to CNBr-activated sepharose 
column and in this confirmation mimic the native attachment on the cell surface.  
 
3.8  Capillary Electrophoresis 
 
Capillary electrophoresis (CE) is the second technique used in this study to evaluate peptide 
binding to glycosaminoglycan. The theory regarding this method is extrapolated in the following 
section.   
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Electrophoresis describes the movement or migration of ions in an electric field. The electric 
force that the ionized species experience, balanced by its frictional drag through a buffer solution, 
determine the mobility of the molecule. The principle of separation by electrophoresis of various 
ionized molecules lays in the differences of the solutes velocities in the electric field as they migrate 
through a capillary tube. A typical capillary electrophoresis instrumental set up (Fig. 16A), consists 
of a high voltage power supply (0-30 kV), a fused silica (SiO2) capillary, two buffer reservoirs, two 
electrodes and an online-UV detector. Sample analysis using capillary electrophoresis, includes 
initial sample injection in a narrow zone from one of the ends of the capillary by either pressure or 
voltage after which the analyte moves along the capillary as a result of the sum of the 
electrophoretic mobility and is dragged by the electroosmotic flow in the fused silica capillary 
(Heegaard 1998). There are various modes of operation used in capillary electrophoresis, capillary 
zone electrophoresis (CZE) being the simplest one. In the analysis procedure the capillary is filled 
with the electrolyte (run buffer) and the sample is introduced from the inlet, after which an 
electrical field is applied. 
 
Figure 16. Capillary electrophoresis experimental set up (A) and illustration of the electrical double 
layer at the capillary wall (B).  At low pH the silanol groups (SiOH) in uncoated silica fused capillary will 
mainly be deprotonated, (SiO
-
). Cations from the buffer solution will be therefore attracted to the wall and 
form a tight layer called the Stern layer. This layer is covered by the diffuse layer, where the cations are in a 
less tight form. When an electric filed is applied, the cations from the diffuse layer will migrate towards the 
negative electrode (cathode), resulting in net movement of the rest of the solution creating the electroosmotic 
flow (EOF). 
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3.8.1 Electrophoretic mobility  
 
The successful separation of molecules in a mixture depends on two principal factors; the 
electrophoretic mobility and the electroosmotic flow (EOF) of the species. The separation relies on 
the migration velocity of the analyte which is expressed as: 
                                                     ν = µe × E                                                              Eq. 2 
where v is the ion migration velocity, µe is the electrophoretic mobility and E is the electric field 
strength. The electrophoretic mobility determines how fast the ion moves through a given medium 
or buffer solution. The equation that describes the electrophoretic mobility, µe is the following: 
                                               µe =
𝒒
𝟔𝝅𝜼𝒓
                                                        Eq. 3 
where q is the charge of the ion, ɳ is the viscosity of the solution and r is the ion radius. The charge 
of molecule functional groups is affected by the pH of the buffer. From the above equation, it can 
be seen that the difference in the µe is dependent on the charge-to-size ratio of the ions. Higher 
charge and smaller ion size confer greater mobility and smaller charge and bigger ion size confer 
slower mobility (Fig. 17A). The electrophoretic mobility of the ion in a given medium (buffer 
solution) will always be constant, which is specific property for that ion. Therefore, due to the 
differences in the electrophoretic mobilities, by capillary electrophoresis it is possible to separate 
mixtures of different ions (Xu 1996; Jimidar 2008). 
3.8.2 Electroosmotic flow 
 
The electroosmotic flow, µeof, is the bulkflow in the capillary as a consequence of the surface 
charge on the interior wall. To exemplify, in most capillary electrophoresis analysis, an uncoated 
fused-silica capillary is used. The interior of the capillary contains silanol groups (SiOH) that above 
pH of 4 exist in anionic form (SiO
-
) giving the capillary wall a negative charge. When buffer runs 
through the capillary, the positively charged ions will be attracted to the negatively charged 
capillary wall (Fig. 16B), creating a diffuse double layer and potential difference (zeta potential 
close to the wall). The layer is also referred to as Sterns layer according to the Stern’s model of 
charge distribution next to the capillary wall. When a voltage is applied, the cations that are forming 
the diffuse double layer are attracted to the cathode. Since they are solvated they will drag the bulk 
solution, resulting in a net flow towards the cathode. The EOF magnitude can be expressed in terms 
of velocity by the following equation: 
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                                              νeof =
𝜻 𝜺
𝜼
× 𝑬                                                               Eq. 4 
where veof is the velocity, ε is the dielectric constant of the buffer, ζ is the zeta potential. The EOF 
varies with pH, being the greatest at high pH where the silanol groups are predominantly 
deprotonated. The electroosmotic flow is presented by the following equation: 
                                          µeof   =  
𝜻 𝜺
𝜼
                                                    Eq. 5 
The apparent electrophoretic mobility of the ion, µa , is the sum of the electrophoretic mobility and 
the electroosmotic flow (Eq. 6). It is the effective speed of migration of the molecules inside the 
capillary. 
                                       µa   =    µe    +    µeof                                                       Eq. 6 
The samples are normally introduced at the anode and since the EOF moves from the anode to the 
cathode, cations have positive µe, neutrals have zero µe and anions have negative µe (Fig.16) 
(Technologies ; Xu 1996; Jimidar 2008). 
 
Figure 17. Migration and electropherogram signals of differently charged species. A) Mobilities of 
negatively and positively charged species and neutrals. Cations with high charge and small size will migrate 
faster towards the cathode as illustrated by Eq.3. B) Electropherogram showing the separation of a cation 
(red), a neutral (blue) and an anion (black), based on longer injection times as used in the CE-FA principle 
(plateau peaks). 
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3.8.3 Capillary electrophoresis frontal analysis  
 
Protein/peptide analyses, exhibit the most challenging analytical tasks due to their complex 
structures, electric charge and behavior in various environments (pH, ionic strengths, 
hydrophobicity etc.). Despite the difficulty, the demand for understanding of their specific 
conformations and interactions in biological samples is increasing. In the past 20 years, capillary 
electrophoresis has proven to be a powerful laboratory tool in peptide analysis especially for peptide 
mapping, analysis of peptide fractions purified by HPLC/FPLC, peptide separation and peptide 
interactions with various biomolecules of interest. Capillary electrophoresis methods provide short 
analysis time (usually less than 30 min) and good compatibility with small sample volumes. 
Capillary electrophoresis is a suitable technique that reveals information about peptide-ligand 
interactions, which is one of the challenges in this study. Capillary zone electrophoresis mode of 
analysis is often a good choice for peptide analysis due to the ability to work near physiological pH 
where the peptides carry net positive charge. During these analyses the analyte is in free solution, 
meaning that the capillary is filled with buffer only.  
The use of capillary electrophoresis in molecular interaction studies has been reported 
(Heegaard 1998; Heegaard and Kennedy 1999; Ostergaard and Heegaard 2003; Volpi, Maccari et 
al. 2008). The principle of measuring  the binding of certain ligand to specific molecules lies in the 
difference in the electrophoretic mobility of the ligand in bound and free state (Heegaard 1998). 
Several methods have been developed to study molecular interactions by capillary electrophoresis, 
e.g., affinity capillary electrophoresis (ACE), which detects the change in the electrophoretic 
mobility of an injected solute in addition to vacancy affinity CE and Hummel and Dreyer principles 
that use the peak area to calculate bound analyte concentration. Pre-equilibrium capillary zone 
electrophoresis uses the peak area and the peak height measurements whereas frontal analysis 
continuous capillary electrophoresis and capillary electrophoresis frontal analysis (CE-FA) quantify 
the interaction by the free ligand concentration detected only from plateau heights.  
The principle behind CE-FA has been described in 1992 by Kraak et al. (Kraak, Busch et al. 
1992).  In frontal analysis the protein and the ligand are premixed and the sample plug is introduced 
in the buffer-filled capillary in relatively large volumes (~60-200 nl). Figure 18 shows peak shapes 
of different volumes introduced in the capillary and the prerequisite of introducing a sample with 
duration of more than 8 sec to observe plateau peak.  
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Figure 18. Effect of injection times for cationic ligand containing sample (Ostergaard, Larsen et al. 
2009).  In capillary electrophoresis frontal analysis to obtain a nicely defined plateau peaks (green) the 
mixture is introduced with long injection time (20-30 sec).  
 
The protein and the ligand are in equilibrium so that the sample plug consists of protein, ligand 
and protein-ligand complex. The difference in the mobility of the protein, the ligand and the 
protein-ligand complex causes the free ligand to leave the protein and protein-ligand complex zones 
(Fig. 19). Equilibrium is maintained where the zones temporarily overlap as the bound ligand is 
released. As a result of ligand migrating away of the overlapping zone,  plateau peaks of the 
released ligand appears on the electropherogram (Fig. 19) (Rundlett and Armstrong 2001). The 
height of the plateau peaks is proportional to the free ligand concentration in the injected sample. 
The free ligand concentration can be calculated from a calibration curve, where a sample containing 
only the ligand is injected. From the known total and free ligand concentration, various parameters 
can be calculated including the degree of biding. The movement of sample plug containing, cationic 
compound, polyelectrolyte and cationic compound-polyelectrolyte complex within a capillary is 
shown in figure 19. 
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Figure 19. Cationic compound-polyelectrolyte complex migration following CE-FA principle (Anderot, 
Nilsson et al. 2009) edited. Initially a pre-equilibrated sample plug containing the cationic compound 
(propranolol, peptides), the polyelectrolyte (chondroitin sulfate) and their complex, is introduced from one of 
the ends of the capillary and an electric field is applied. To the right the data output, the electropherogram 
shows the absorbance on the y-axes and migration time on the x-axes. A) Shows pre-equilibrated sample 
plug introduced into the capillary. B) Due to the different charged states, the cationic compound is easily 
separated from the chondroitin sulfate, migrating faster towards the cathode and away from the sample zone. 
To compensate for the lost cationic compound from the sample zone, the complex dissociates to uphold the 
equilibrium. C) Separated cationic compound reaches the detection zone and appears in the 
electropherogram. The peak height is a measure of the free concentration of the cationic compound in the 
injected sample. D) After the cationic compound has been detected, the signals from the complex and the 
free polyelectrolyte appear on the elution profile.  
 
 Capillary electrophoresis frontal analysis is the method used for the analysis of the peptide 
interaction with the polyelectrolyte of interest in the present study. The advantage of introducing 
capillary electrophoresis frontal analysis in peptide–polyelectrolyte interaction is the short analysis 
time, simple method development, low sample consumption and ease of automation (Ostergaard, 
Khanbolouki et al. 2004; Ostergaard, Hansen et al. 2005; Østergaard, Jensen et al. 2009).  
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3.8.4 Equilibrium binding constant 
 
In order to establish a binding model to determine the binding constant using CE-FA, consider 
an interaction of ligand, L, with chondroitin sulfate, CS to form a complex CSL as in Eq.7:  
                                                      CS + L ⇌ CSL                                                  Eq. 7 
The equilibrium can be described by the equilibrium constant, K defined in Eq. 8: 
 
  LCS
CSL
K 
                                                                        
Eq. 8
 
where, [CS] is the concentration of the free binding sites in chondroitin sulfate and not the polymer 
concentration in the mixture and [L] is the free ligand concentration
 
(Ostergaard, Khanbolouki et al. 
2004). 
 
For construction of binding isotherms, the knowledge of the free ligand concentration helps in 
the determination of the classes of the independent binding sites, the number of binding sites and 
the association equilibrium constant, Ka (Scatchard 1949). The binding density, v, is the average 
degree of binding expressed as the number of moles of the ligand bound per mole of CS groups 
(Eq.9).  
                                                                                     Eq. 9 
where [L]bound,[L]total, and [L]free, are the bound, total and free ligand concentration, respectively. 
The total ligand concentration is the concentration of the ligand in the standards. The free ligand 
concentration is the concentration determined from the linear regression equation from the standard 
curve of the ligand and the measurements obtained from the sample where the ligand interacts with 
the chondroitin sulfate. The Ccs is the molar concentration of the sulfate groups in the sample. 
Sulfate groups are determined from the percentage found in the polymer from where the equivalent 
weight is determined. The apparent association constant, Kapp is then determined from the slope of 
the binding isotherm (v vs. [L]free). The following equation is derived from the equations 8 and 9. 
                 v = [L]bound / [Ccs] = (n Ka  [L]free) / (1  Ka  [L]free)                     Eq. 10 
where n is 1 for the simple model where single class of binding sites is present. Figure 20 shows a 
set of hypothetic binding data that can be fitted in equation 10. 
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Figure 20. Graphical representation of hypothetic binding data. Scatchard plot of v versus [L]free, 
showing a situation from which association constants can be obtained according to equation10.  
4. Materials and methods 
 
4.1  Cell culture 
 
A31 3T3 and NIH 3T3 cells (mouse fibroblast cell lines, obtained from the groups of Bodil Norrild 
and Ole William Petersen, respectively-Panum Institute) were propagated in Dullbecco’s modified 
Eagle’s medium (DMEM) supplemented with 10 % Fetal calf serum (FCS), 1 % glutamine and 100 
IU/ml of penicillin and 100 µl of streptomycin (P/S). HCT-116 (human colon carcinoma epithelial 
cells) were propagated in McCoy 5A medium. HeLa (human epithelial carcinoma cell line, obtained 
from Bo van Deurs group-Panum Institute) were propagated in DMEM supplemented with 10 % 
FCS, 1 % glutamine, 1 % sodium pyruvate and 100 IU/ml of penicillin and 100 µl of streptomycin 
(P/S). HEK 293T cells were propagated in DMEM supplemented with 10 % FCS (Australian), 1 % 
glutamine and 1 % P/S. All cell lines were incubated at 37
°
C, 5 % CO2 and 95 % humidity. 
4.2 Viral production 
 
To generate virus particles wild type amphotropic murine leukemia virus (A-MLV) plasmids 
encoding for the WT Gag/Pol enzymes, amphotropic envelope and GFP-expression (pCNCG) or 
lacZ-expression (pLacZ) vectors were used. In addition, to generate VSV virus particles, plasmid 
encoding for 8.91 (lenti) enzyme, VSV envelope and pHR CMV (GFP) vector were used (table 3). 
HEK 293T cells were seeded in 10 mm dishes and grown to 70 % confluence at 10 % CO2. The 
cells were co-transfected by Calcium Phosphate transfection with plasmids encoding WT Gag/Pol, 
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amphotropic envelope or vesicular stomatitis envelope, GFP-expression vectors and lacZ-
expression vectors. The cells were left over night at 37
°
C, 3 % CO2 (optimal CO2 level for stable 
transformation), followed by medium change and switch to 5 % CO2. After 48hours of transfection 
the medium was harvested, filtered by using 0.45 µM pore size Millex PVDF filters, concentrated 
20 times by using Sartorius filter tubes, and stored at -80
 °
C until use. All the vectors used for viral 
production are listed in table 3. 
Table 3. List of plasmids and amounts used for viral production 
Vector ( 10 µg) Helper plasmid (10 µg) Envelope (5 µg) 
pCNCG (GFP) MLV gag/pol or 8.91 (lenti 15µg) Amphotropic 
pCNCG (GFP) MLV gag/pol or 8.91 (lenti 15µg) Ecotropic  
placZ MLV gag/pol or 8.91 (lenti 15µg) Amphotropic 
pHR CMV (GFP) (20 µg) 8.91 (lenti 15µg) VSV 
Quantities refer to transfection of one 10 cm dish of HEK 293T cells.  
 
4.3   Immunoflourescence 
 
For live imaging studies, the cells of respective cell lines (NIH 3T3, A31 3T3) were seeded onto 
thin bottomed 8 chamber slides (Nunc).The cells were incubated over night at 37
°
C to reach 
confluence. One chamber out of four represented the control chamber containing untreated cells. A 
second one contained cells treated with 100 µg/ml Dextran-FITC (20 mg/ml stock solution of 70 
kDa Dextran-molecular probe) only and a third one contained cells treated with both dextran and 1 
mM amiloride (900 mM in DMSO stock solution) for testing inhibition of dextran uptake. The cells 
were incubated up to 4 hours at 37
°
C. After the incubation time, the cells were carefully washed 
twice with Hank's Buffered Salt Solution (HBSS) and were inspected under a Confocal LSM 510 
META microscope (Zeiss) with filter set FITC 488 nm at 60 times magnification. Images were 
taken and digitalized by using Carl Zeiss software.  
A31 cells overexpressing human PiT-2 were established (A31 (h) PiT-2) by stably transducing them 
with E-MLV that carried the human PiT-2 vector. The cells for the Triton X-100 extraction and 
immunoflourescence studies were seeded onto chamber slides (Nunc) coated with borosilicate. 
They were either left untreated (HBSS, on ice) or were treated with 1 % TX100/HBSS on ice for 15 
minutes before fixation in 2 % paraformaldehyde (PFA). Lipid rafts and proteins contained within 
them are not extracted by 1 % TX100 treatment while the rest of the cell membrane will dissolve. 
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After PFA removal, the cells have been thoroughly washed with Phosphate-buffered saline devoid 
of Calcium and Magnesium (PBS -/-) and incubated in PBS-NGS-saponin for 15 minutes and then 
overlaid with primary antibodies against caveolin 1 (Cav-1 PAC rabbit polyclonal antibody, 
Transduction Laboratories), PiT-2 (rabbit polyclonal antibody, Novus) and lamin.  After one hour 
incubation with the primary antibodies, the cells were washed with PBS-/- and overlaid with the 
secondary antibodies. After a final washing step with PBS and dH2O, the slides were coverslipped 
with immunoflourescence mounting medium (Fluoromount), left to dry and inspected under the 
confocal LSM stated above with additional filter sets of Texas Red 595-619 nm for imaging. 
Images were taken, digitalized and merged by using Carl Zeiss software by Frederik Vilhardt.   
4.4  Flow cytometry and viral infection 
 
To test the viral infectivity on various cell types, cells were seeded in 24 well plates and grown to 
80 % confluence. Different volumes of virus were added and the cells were incubated overnight at 
37
°
C, 5 % CO2. Virus containing medium was removed, the cells washed with PBS-/- followed by 
addition of fresh medium, after which the cells were cultured overnight. The next day, the cells 
were washed with PBS-/-, trypsinized and suspended in PBS-/- by pipetting and placed on ice. 
Flow cytometry quantitative analyses of the infected cells were immediately performed. Beckton 
Dickinson FACSAria flow cytometer and FACS Diva software were used for the analysis. GFP-
expressing amphotropic murine leukemia virus (A-MLV GFP) and vesicular stomatitis virus (VSV 
GFP) were used for the flow cytometry studies.  
4.5  Inhibition of viral entry 
 
Amiloride (900 mM stock in DMSO) and amiloride analogue ethylisopropylamiloride (EIPA) (100 
mM stock in DMSO) were used as macropinocytosis inhibitors. The cells were incubated overnight 
with different concentrations of the inhibitors prepared in culture medium in parallel with A-MLV 
GFP, A-MLV lacZ or VSV GFP. Quantification of the infected cells was measured by flow 
cytometry (A-MLV GFP and VSV GFP) and ELISA reader (A-MLV lacZ) after 48 hours of 
infection.  
4.6  Host defense peptides 
 
Peptides used in the present study are LL-37 (2 mg/ml stock solution), bovine lactoferrin (BLF) (2.1 
mg/ml stock solution), lactoferricin B (LfcinB) (2.1 mg/ml stock solution) 1018 (2 mg/ml stock 
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solution) and NisinA (4 mg/ml stock solution). Peptide stock solutions were prepared in MiliQ 
water and kept at -20
°
C. LL-37 and 1018 have been synthesized by solid phase peptide synthesis 
and purified using reverse-phase HPLC. Bovine Lactoferrin, purchased from Sigma Co. (St. Louis, 
MO, USA) has been purified from non-pastured diary milk. Bovine lactoferricin was purchased 
from the Center for Food technology (Hamilton, Qld, Australia). NisinA (500 µM stock solution in 
water) was purchased from Sigma (N5764) and further purified by reverse-phase FPLC. 
4.7  LDH assay and Trypan Blue 
 
For higher viral infectivity, the cells were incubated for 24 hours with A-lacZ. For validating the 
peptide effects on virus infection, the cells were also exposed to different peptide concentrations in 
the virus inoculums and incubated for 24 hours at 37
°
C. For this purpose, the working 
concentrations of the different peptides giving the lowest cytotoxicity were determined by LDH 
assay. The lactate dehydrogenase colorimetric assay, quantifies plasma membrane damage. LDH is 
present in the cytoplasm in all cells and is membrane impermeable. When the cell membrane is 
damaged, LDH is immediately released in the culture supernatant. The LDH release was measured 
by and the cytotoxicity of the peptides on A31 cells was evaluated. In addition, trypan blue was 
used for visible cell lyses at different peptide concentrations (data not shown). 
4.8  β-galactosidase assay (X-gal) 
 
Beta-gal staining solution containing 1 mg/ml Bromo-chloro-indolyl-galactopyranoside (X-gal, 40 
mg/ml in DMF stock solution stored at -20
°
C), 5 mM Potassium Ferrocyanide (K4Fe) and  5 mM 
Potassium Ferricyanide (K3Fe) in dH2O and 2 mM MgCl2 (1M stock solution), in PBS-/- was 
prepared fresh before staining. 
Cells previously transfected with viral particles encoding lacZ gene were grown to 80% confluence 
in 10 cm dishes. The medium was removed and the cells were gently washed 2-3 times with PBS-/- 
after which they were fixed in ice cold 0.2% glutaraldehyde in PBS for 5 minutes at room 
temperature. After removal of glutaraldehyde and thorough washing with PBS-/-, 7 ml of the β-gal 
staining solution was added to the dish and the cells were incubate at 37
°
C until color appeared (1-
24 hours). Blue colored cells were observed and images were taken using light microscope (Leica 
Microsystems).  
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4.9  Micro β-galactosidase assay (ONPG) 
 
Z buffer containing 60 mM NaH2PO4, 10 mM KCl and 1 mM MgSO47H2O in dH2O, adjusted to pH 
7 was used. O-Nitrophenyl-β-D-Galactopyranoside (ONPG) was purchased from Sigma and 
dissolved in Z buffer giving final concentration of 4 mg/ml. 1M Na2CO3 in water was used as a stop 
buffer. Lysis buffer containing ONPG, 0.1%TRX100 in Z buffer was prepared before use.  
For viral infectivity measurements, a microplate assay was developed using a model amphotropic 
recombinant retrovirus encoding lacZ gene (A-MLV lacZ). The day before infection, A31 cells (10 
000 cells/well) were seeded in 96 well plate and incubated at 37
°
C, 5 % CO2. 30 µl of A-MLV lacZ 
virus was added to the wells and 50 µl of peptides (each calculated to reach desired final 
concentration in final volume of 200 µl per plate) and left for incubation 4-5 hours, after which the 
inoculum was removed and replaced with fresh culture medium. The cells were further incubated at 
37
°
C
 
for more than 24 hours. After the incubation period, the cells were washed once with 200 µl 
PBS-/- and 50 µl of Z buffer was added to each well and incubated for 30 minutes. After 30 min the 
Z buffer was replaced with 20 µl of lysis buffer and the plate was incubated for 2 hours at 37
°
C. The 
reaction was terminated by addition of 50 µl stop buffer (1M Na2CO3) which shifts the reaction 
mixture to pH 11 where most of o-nitrophenol turns into yellow anionic form (Fig. 21). The plate 
was read on ELISA reader, where the absorbance at 420 nm was quantitatively measured. 
Uninfected cells treated with Z buffer only were used as a negative control. 
 
Figure 21.Enzymatic hydrolysis of o-nitrophenol- β-galactoside (ONPG) to o-nitrophenol (ONP) and 
galactose by β-galactosidase. The enzymatic hydrolysis results in a formation of a yellow color which is 
detected at 420 nm, the max absorption of ONP. 
 
 
ONP 
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4.10 FPLC -Affinity assay 
 
Heparan sulfate from bovine kidney was from Seikagaku Corporation Inc. (Rockville, MD), 
chondroitin sulfate A Na salt (400658-1A, AMS Biotechnology), nisin A, bovine lactoferricin, 
bovine lactoferrin, LL-37, 1018 and  propranolol hydrochloride was obtained from Sigma (St. 
Louis, MO, USA). CNBr-activated sepharose was purchased from Amersham Pharmacia, Biotech 
(Uppsala, Sweden) (Jenssen, Andersen et al. 2004). 
CNBr activated sepharose affinity column, using heparan- or chondroitin sulfate as ligands was 
prepared. The ligands were mixed with CNBr-activated sepharose and the mixture was applied in a 
column. The peptides applied were dissolved in distilled water and 100 µl of each peptide was 
applied. 1 M NaCl gradient was used to elute different peptides from the column using FPLC at a 
flow rate of 1.0 ml/min. The peptides were then detected at 214 nm. 
4.11 Capillary electrophoresis frontal analysis  
 
The capillary electrophoresis experiments were performed on a Hewlett Packard
3D
 (Agilent, 
Waldbronn, Germany) capillary electrophoresis instrument. The capillaries used for the peptide 
analysis and their properties are listed in table 4.  
Table 4. List of different capillaries and their properties 
Capillaries 
 
Coating Properties 
Uncoated silica fused* – bare silica capillary  
 
Shows measurable EOF  
31.2 cm (total length) 
20 cm to the detector 
50 µm I.D 
PVA** Permanently coated with 
highly hydrophilic poly(vinyl 
alcohol) 
Shows no measurable EOF  
31.2 cm (total length) 
20 cm to the detector 
50 µm I.D 
CEP coated ** 
 
Permanently coated with 
hydrophilic polymer 
Shows no measurable EOF in 
pH range of 2.5 to 8. 
33.5 cm (total length) 
24 cm  to the detector 
75 µm I.D 
Neural*** Neutral capillary Shows no measurable EOF 
33.5 cm (total length) 
50 µm I.D 
*Polymicro Technologies, Phoenix, AZ, USA ** (Agilent Technologies, Waldbronn, Germany)    
*** (Beckman Coulter, USA)  
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A 67 mM phosphate buffer was used as a running buffer, titrated to a pH of 7.4 with HCl. All 
buffers were filtered through 0.45 µm pore size nylon filters before use.The polarity of the 
instrument was set in normal mode, i.e. the cathode was at the injection end of the capillary. 
Propranolol hydrochloride (10 mM stock solution in 67 mM phosphate buffer) was used as a 
cationic model compound (Fig.22). All the peptides in this study were diluted in water with addition 
of TFA to aid solubility. The peptides were stored at -20
°
C and thawed before use. Desired working 
concentrations were prepared fresh in the working buffer prior to use. DMSO (0.1 %) was used as a 
neutral marker for EOF determination. 0.5 mM propranolol was used as a standard cationic model 
compound for capillary signal check. Chondroitin sulfate (sodium salt) from bovine cartilage was 
obtained from Sigma (St. Louis, MO, USA). 25 mg/ml Chondroitin sulfate (CS) was used as a 
working concentration in all mixtures. This corresponds to 0.52 x 10
-1 
M
 
if repeating units of CS is 
assumed to have molecular formula C14H20NNaO14S. 
 
Figure 22. Propranolol structure. Propranolol has pKa value of 9.2 meaning that at physiological pH of 7.4 
it will carry one positive charge at the amino group. 
Capillary electrophoresis of the samples was performed on Hewlett Packard 
3D
, Germany, 
equipped with diode-array detector, operated by HP ChemStation software. The samples were 
diluted in the working buffer and the ionic strength of the samples was kept constant in all samples. 
The samples were run on uncoated fused-silica capillary, preconditioned with 1 M NaOH, milliQ 
water and phosphate buffer. The capillary was kept at 25
°
C. Each time before use the capillary was 
flushed for 10 min with 0.1 M NaOH and 5 min with phosphate buffer. The inlet end of the 
capillary is immersed in the sample vial and a pressure (0.5 psi) is applied to initiate sample 
introduction and separation process. The samples were generally introduced for 30 sec and 8 kV 
was applied. After each run the capillary was reconditioned with 0.1 M NaOH (2 min) and 
phosphate buffer (2 min). Additional cleaning steps regarding the peptide adsorption to the capillary 
wall included flushing the capillary with 1 M NaOH and 2 M HCl. Regarding the PVA, CEP and 
the neutral capillaries, for conditioning purpose 10 mM phosphoric acid, milli-Q water and 
electrophoresis buffer were used. The detection wavelengths were 200 nm, 214 nm and 280 nm.   
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5. Results  
 
5.1  Immunoflourescence studies 
 
Macropinocytosis is used as an entry route by many viruses (Mercer and Helenius 2009) (table 
1). Fluid uptake by cells via macropinocytosis can be monitored by the use of 70 kDa dextran 
molecules as fluid phase marker, as it is too big to be internalized by pinocytosis (Mercer and 
Helenius 2008). Therefore, we began this study by characterizing whether macropinocytosis is 
active in mouse fibroblast cell lines using FITC-labeled dextran. A31 wt cells were treated with 
FITC-Dextran for up to 4 hours in presence or absence of amiloride, after which the dextran uptake 
was monitored by live cell imaging using confocal microscopy.  Dextran is internalized by A31 wt 
cells, indicating that macropinocytosis is active (Fig. 23). Next, we investigated the effect of 
amiloride on dextran uptake. Amiloride is a well known macropinocytosis inhibitor without 
affecting other endocytic pathways (West, Bretscher et al. 1989). Decrease in dextran uptake in 
cells treated with amiloride was observed, confirming that macropinocytosis was inhibited (Fig. 
23).   
 
Figure 23. FITC-Dextran uptake in A31 wt cells without and with amiloride. A31 wt cells treated with 
100 µg/ml FITC-dextran only (left) and100 µg/ml FITC-dextran and 1mM amiloride (right) were incubated 
at 37
°
C for 3-4 hours. The uptake of fluorescently labeled dextran was compared with that in the untreated 
cells. The fluorescent signals in amiloride treated cells were compared with the untreated and dextran treated 
cells (positive control).  
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5.2  Infection studies 
 
To test the susceptibility of A31, NIH 3T3, HeLa and HCT-116 cells to A-MLV infection, the 
cells were incubated with A-MLV GFP for 20 hours. The virus containing medium was removed 
and replaced with fresh and the cells were incubated for further 24 hours to allow transgene 
expression. The cells were then prepared for flow cytometry analysis, where the percentage of cells 
expressing GFP was determined. Graphic representation of the flow cytometry analysis with 
regards to A31 wt and HeLa cells is illustrated in figure 24. P1 gating encloses cells (represented by 
red dots) that received no virus, and are used as a control cells (Fig. 24-1A,B). Out of the P1gating, 
GFP expressing cells are shown within P2 gating (Fig. 24-2A,B). As a result of A-MLV infection in 
A31 and HeLa cells, the number of infected cells (green dots) has increased in comparison to the 
control cells (Fig. 24-3A,B). Flow cytometry analysis, as illustrated in figure 24, were performed 
for all respective cell lines. A31 wt cells show higher viral infectivity than HCT-116, HeLa and 
NIH 3T3 cells (Fig. 25).  
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Figure 24.  Flow cytometry analysis of A31 wt and HeLa cells. Graphic representation of the analysis of 
infected A31 (A) and HeLa (B) cells. Row 1A and B shows the forward scatter versus side scatter dot plot of 
A31 and HeLa cells, respectively. It shows the number of cells analyzed within specific gating (P1). Rows 2, 
3, 4 and 5 shows the GFP-expressing, infected cell population out of the P1 population within P2 gating. 
Cells that received no virus (controls) are shown in 2 A and B. Row 3 shows the population of A-MLV GFP 
infected cells. Rows 4 and 5 show the A-MLV GFP infected population of cells treated with amiloride (0.5 
mM) and EIPA (50 µM) respectively.  
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Figure 25. Viral susceptibility in four different cell types. Wild type mouse fibroblasts A31, NIH 3T3 and 
human epithelial cell types HeLa and HCT-116 were incubated with equal amounts of A-MLV GFP 
overnight and analyzed by flow cytometry after a day of cell culture. Y-axis shows the percentage of A-
MLV GFP infected cells. Data represent mean and standard error of the mean (SEM) bars of 3-4 individual 
experiments. 
 
Assuming that A-MLV enters by macropinocytosis, amiloride and EIPA treatment should decrease 
infection. To investigate this hypothesis the effect of amiloride and the amiloride derivative, ethyl 
isopropyl amiloride (EIPA) on A-MLV internalization, was assessed. The cells were incubated with 
A-MLV GFP with addition of the respective inhibitors for 20 hours. After removal of the viral 
inoculum and incubation for an additional 24 hours the cells were analyzed by flow cytometry as 
described earlier. In figure 24-4A,B and 24-5A,B a decrease in A31 and HeLa cell population 
within P2 gating is observed when compared to 24-3A,B. The decrease in the fluorescence signals 
is a result of A-MLV inhibition upon amiloride and EIPA treatments, EIPA being the most 
effective. Viral inhibition is observed in all cell lines and summarized in figure 26.  
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Figure 26. A-MLV-GFP infection in the four cell types.  A31 cells are the most susceptible to A-MLV 
GFP infection, whereas NIH 3T3 show the least infectivity. The inhibition of A-MLV GFP infection with 
amiloride and its more potent analog EIPA is observed in all cell lines. Data represent mean values of 3-4 
individual experiments.  
 
Further on, to test the specificity of inhibition of amiloride and EIPA on A-MLV entry, GFP-
expressing viral particles carrying vesicular stomatitis virus envelope were produced. Vesicular 
stomatitis virus (VSV) enters the cells by clathrin-mediated endocytosis (Sun, Yau et al. 2005), 
therefore amiloride and EIPA treatment should not inhibit the internalization. A31 wt, NIH 3T3, 
HeLa and HCT-116 cells were infected with each virus (A-MLV GFP and VSV GFP) separately 
and incubated for 20 hours. In parallel, the cells have been incubated with or without 
macropinocytosis inhibitors. After removal of the viral inoculum the cells were cultured for an 
additional 24 hours after which flow cytometry was performed to determine the number of A-MLV 
GFP and VSV GFP infected cells as previously described. A31 wt cells are more susceptible to A-
MLV infection than VSV. The same is inhibited by both amiloride and more profoundly EIPA. 
There is no significant difference between A31 wt cells infected with VSV GFP in presence or 
absence of amiloride (Fig. 27).  
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Figure 27.  A-MLV GFP and VSV GFP infection in A31 cells analyzed by flow cytometry. The cells 
were incubated with A-MLV GFP and VSV GFP in presence of 0.5 mM amiloride and 50 µM EIPA. A-
MLV GFP shows higher infectivity compared with VSV GFP. A-MLV GFP infection is successfully 
inhibited by amiloride and EIPA which do not however affect VSV GFP infection. Data represent mean and 
SEM of 3-4 individual experiments.  
NIH 3T3 cells show similar susceptibility to A-MLV and VSV infection. A-MLV infection in NIH 
3T3 cells was inhibited by amiloride and EIPA in contrary to the VSV GFP infection (Fig. 28). 
 
Figure 28. A-MLV GFP and VSV GFP infection in NIH 3T3 cells analyzed by flow cytometry. The 
cells were incubated with A-MLV GFP and VSV GFP in presence of amiloride and EIPA.A-MLV GFP 
shows similar infectivity compared with VSV GFP. A-MLV GFP infection is successfully inhibited by 
amiloride and EIPA. Amiloride does not inhibit VSV GFP infection, in contrary it contributes to a slight 
increase in VSV infection. Data represent mean and SEM of two individual experiments (one experiment for 
NIH 3T3 cells treated with EIPA). 
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HeLa and HCT-116 cells also appeared to be prone to A-MLV infection followed by inhibition of 
the same by amiloride and EIPA (Fig. 29). HCT-116 cells are more susceptible to A-MLV infection 
than HeLa cells.  
 
Figure 29.  A-MLV GFP infection in HeLa and HCT-116 cells analyzed by flow cytometry. The cells 
were incubated with A-MLV GFP in the presence of amiloride or EIPA, which both inhibit infection. Data 
represent mean and SEM of 2-3 individual experiments.  
 
VSV GFP infectivity in HeLa and HCT-116 cells, when 20 µl of virus was added was saturating. 
Therefore the flow cytometry analysis regarding VSV infection in these cell lines were repeated 
with lower viral titers of 0.5, 1 and 2 µl VSV GFP. The percentage of VSV GFP infected HCT-116 
cells was determined by flow cytometry as previously described and is illustrated graphically in 
figure 30. 12.2 % of the HCT-116 parent population (cells within P1) is infected upon addition of 
0.5 µl of VSV GFP (Fig. 30C) and increase of viral infectivity is observed as the amount of virus 
added is raised. Amiloride (0.5 mM) and EIPA (50 µM) affected HCT-116 and HeLa cells 
morphology (cells rounded up) and contributed to increased cell death. Therefore the amiloride and 
EIPA concentrations were decreased to 0.25 mM and 25 µM, respectively.  In HCT-116 cells VSV 
GFP infection was stimulated in presence of amiloride from 25 % infected cells treated without 
amiloride to 47 % infected cells treated with amiloride (Fig. 30D,F). No significantly change in 
VSV GFP infection was observed when the cells were treated with EIPA (Fig. 30D,G). In 
summary, the experimental data shows high VSV GFP infectivity in both cell lines, which 
decreases in HeLa cells upon amiloride and EIPA treatment (Fig. 31).  
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Figure 30. Flow cytometry analysis of HCT-116 cells. A, B) Graphic presentation of uninfected HCT-116 
control cells within P1gating and GFP-expressing cells within P2 gating. C) HCT-116 cells that had received 
0.5 µl VSV GFP show 12.2 % of GFP expressing cell population. D) As the viral titer was increased to 1µl 
VSV GFP, an increase in the percentage of the infected population is observed. E) 2 µl VSV GFP results in 
higher percentage of infected cells (39 %).F) HCT-116 cells that have received both 1 µl VSV GFP and 0.5 
mM amiloride show an increase of the GFP expressing population when compared with the cells containing 
1 µl of VSV GFP only. G) Slight increase in VSV GFP infected HCT-116 population treated with EIPA (25 
µM) is observed.  
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Figure 31. VSV GFP infection in HCT-116 and HeLa cells analyzed by flow cytometry. Since 20 µl of 
VSV GFP showed infection saturation in HCT-116 and HeLa cells, different viral titer was tested. The cells 
were incubated with VSV GFP (1 µl) along with amiloride or EIPA.VSV GPF infection in HCT-116 cells is 
stimulated in the presence of amiloride and is not significantly changed in the presence of EIPA. Amiloride 
and EIPA inhibited VSV-GFP infection in HeLa cells. Data represent values from one experiment.  
 
5.3  PiT-2 association with lipid rafts 
 
It has been claimed that A-MLV enters via caveolae (Beer, Andersen et al. 2005). To address 
this possibility we examined the association of PiT-2 receptors with lipid rafts by 
immunoflourescence studies. Caveolin proteins are major proteins of cell surface caveolae, 
specialized form of lipid raft domains (Martin and Parton 2005). It has been shown that proteins 
that are localized in the lipid raft regions of the plasma membrane are insoluble in nonionic 
detergents such as Triton X-100 at 4
°
C (Simons and Ikonen 1997). In order to analyze whether PiT-
2 associates within these macrodomains, A31 (h) PiT-2 cells (see Materials and Methods section) 
were treated with 1% Triton X-100 at 4
°
C. The cells were then stained for human PiT-2 receptor 
((h) PiT-2) and low-density-lipoprotein receptor (LDLR). LDL receptor is used as a positive 
control: it is not-lipid raft-associated and therefore will be extracted. By contrast neither caveolin1 
(lipid raft-associated) nor lamin (nuclear intermediate filament) are extracted by Triton X-100 
(negative controls). As shown in figure 32, most of the PiT-2 and LDLR were both extracted upon 
1% Triton X-100 treatment, indicating that most of PiT-2 resides in membranes outside lipid rafts.  
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Figure 32. PiT-2 is not associated with lipid rafts. A31 (h) PiT-2 cells were treated with 1% Triton X-100 
4
°
C, then fixed and stained for Caveolin-1, (h) PiT-2, LDLR and lamin. Control cells stained for (h) PiT-2 
(green) and LDLR (red) are shown in the first row. Most of the (h) PiT-2 and LDLR (positive control) 
signals are absent due to TX-100 extraction. Lower row: Overlaid image shows colocalization of (h) PiT-2 
receptor with LDLR in endosomes. Caveolin is associated with lipid rafts as it stays intact upon TX-100 
extraction. Lamin is also not extracted by TX-100 (negative control).   
  
55 
 
5.4  Effects of Peptides on viral infection 
 
Peptides exhibit antimicrobial properties on various bacteria and viruses (Jenssen, Hamill et al. 
2006). To investigate the interference of LL-37, 1018, lactoferricin B (LfcinB) and bovine 
lactoferrin (BLF) with A-MLV internalization, microplate β-galactosidase assay was developed.  A 
model amphotropic recombinant retrovirus encoding lacZ gene (A-MLV lacZ) was used for viral 
infectivity measurements. The initial studies involved titration of different peptide concentrations in 
presence of A-MLV lacZ in order to see how different peptide concentration ranges affects viral 
internalization and to see whether the peptides within the working concentration range would affect 
the cell morphology. The cells were incubated with different peptide concentrations along with 
equal amount of A-MLV lacZ for 5 hours during which no significant change in cell morphology 
was observed. The inoculum was then removed and the cells were cultured for an additional 24 
hours after which they were prepared for ONPG analysis. Three sets of control cells were analyzed. 
One set of cells received peptide only, a second set received virus only (positive control) and a third 
set of cells received neither peptide nor virus (negative control).  A-MLV lacZ internalization was 
stimulated in presence of all of the peptides with 1018 having the greatest impact (Fig. 33). For 
LfcinB, 1018 and BLF an increase of viral infectivity was observed in a concentration dependent 
manner. The higher the peptide concentration, the higher the viral infection observed (Fig. 33). In 
contrary LL-37 effect on viral infectivity demonstrated increase of A-MLV lacZ infection as lower 
peptide concentration was added (Fig. 33).  
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Figure 33.  Effect of different peptide concentrations on A-MLV lacZ viral infection in A31 wt cells. 
A31 wt cells (10000 cells/well) were seeded in a 96 well plate and incubated over night to reach 
subconfluence. The following day the cells were treated with different peptide concentrations in absence and 
presence of A-MLV lacZ for 5 hours. The viral inoculum was then removed and fresh medium was added 
after which the cells were incubated for an additional 24 hours. The absorption value of the negative control 
(uninfected cells) was subtracted from all the values. The absorption values are proportional to the amount of 
β-galactosidase expressed in the cells and indicate the degree of infection in the β-galactosidase-A31 wt 
positive cells. The degree of infection of cells treated with peptide and virus inoculum is compared with cells 
that have received virus only. Blue bars show absorption of cells that received peptides only, green bars 
show absorption  of cells infected with A-MLV lacZ and the red bars correspond to absorption values of 
cells treated with both peptide and virus.  Each bar shows mean value of two replicates from one experiment. 
 
 
5.5  Amiloride and EIPA inhibit A-MLV lacZ internalization in presence of peptides 
 
Due to the observed increase of viral infection in A31 wt cells together with the established 
internalization of A-MLV lacZ, the probability that the peptides could stimulate internalization of 
A-MLV lacZ by upregulating the macropinocytosis process was speculated. We investigated this 
hypothesis by treating the cells with peptide and virus inoculum in parallel with macropinocytosis 
inhibitors, amiloride and EIPA. At first the cells were treated with A-MLV lacZ in presence of 
macropinocytosis inhibitors to check whether the inhibition observed in the flow cytometry studies 
is consistent and to check for the sensitivity of the measurements.  
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The results demonstrated a successful inhibition of A-MLV lacZ infection in A31 wt cells by 
amiloride and in particular EIPA and they are in agreement with the flow cytometry analysis (Fig. 
34). 
 
Figure 34. The effect of amiloride and EIPA on A-lacZ internalization in A31 wt cells. The cells were 
incubated with A-MLV lacZ in presence of macropinocytosis inhibitors amiloride (0.5 mM) and EIPA (50 
µM). Inhibition of viral entry is observed with both amiloride and the more potent amiloride analogue, EIPA. 
The negative control (absorption of uninfected cells) is subtracted from all the absorption values. Data 
represent mean and SEM of two individual experiments.  
For the experiments including macropinocytosis inhibitors, amiloride and EIPA, the peptides LL-
37, bovine lactoferrin and 1018 were selected. No significant change in viral infection was observed 
in the cells treated with LL-37 (Fig. 35). However this infection was completely restrained in 
presence of amiloride and EIPA. Next, increased viral infection was still observed in the cells 
treated with bovine lactoferrin and 1018 and the results demonstrate inhibition of the viral infection 
by amiloride and EIPA (Fig. 35). 
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Figure 35.  Amiloride and EIPA decrease the viral infectivity in presence of peptides in A31 wt cells. 
The cells were incubated with equal amounts of A-MLV lacZ in presence of LL-37, BLF and 1018. Cells 
treated with peptide, virus and macropinocytosis inhibitors amiloride (0.5 mM) and EIPA (50 µM) are shown 
with purple and blue bars, respectively. Inhibition of viral entry is observed with both amiloride and EIPA. 
The negative control (absorption of uninfected cells) is subtracted from all the absorption values. Data 
represent mean values of two replicates from one experiment.  
The overall effect of the LL-37 and 1018 peptides on A-MLV lacZ infection in A31 wt cells 
together with the effect of macropinocytosis inhibitors on the same internalization is summarized on 
figure 36. In general the results point out that in presence of LL-37 and 1018 the susceptibility of 
A31 wt cells to A-MLV lacZ infection is increased (Fig. 36). As illustrated by the purple and blue 
bars for amiloride and EIPA, respectively, the increase of viral uptake is inhibited (Fig. 36).  
The peptides were previously dissolved in water, and diluted in medium for the final concentrations. 
However to exclude any water effect on cell behavior that may interfere with the observed effect of 
the peptides to A-MLV lacZ infection, the cells were treated with the same amount of water and 
virus as in the peptide dilutions. The results show that water had a minor impact on A-MLV 
internalization and is not responsible for the greater viral intake observed in presence of LL-37 and 
1018 (Fig. 36).  
 
Figure 36. The effect of the human cathelicidin host defense peptide, LL-37 and 1018 on A-MLV lacZ 
infection in A31 wt cells. The cells were incubated with 30 µg/ml LL-37 and 100 µg/ml 1018 for 5 hours in 
presence of equal amounts of A-MLV lacZ. The inoculum was then removed and fresh medium added to the 
cells. The cells were incubated for an additional 24 hours to allow transgene expression. In parallel cells 
were treated with peptide, virus and macropinocytosis inhibitors and their absorption values are shown in 
purple and blue for amiloride and EIPA, respectively. Absorption values of cell that received water and virus 
in the same manner as peptides and virus the only difference being the peptide are shown in orange. The 
viral infectivity was quantitatively measured by ONPG assay as described in the Materials and Methods 
section. The negative control (absorption of uninfected cells) is subtracted from all absorption values. Data 
represent mean and SEM of sets of 2-4 individual experiments.  
-0.050
0.000
0.050
0.100
0.150
0.200
0.250
0.300
LL-37                                       1018
A
b
so
rb
a
n
ce
 4
2
0
n
m
 (
O
N
P
G
) 
peptide
virus 
peptide+virus
peptide+virus+amiloride
peptide+virus+EIPA
water+virus
  
59 
 
Two different concentrations of bovine lactoferrin were tested for their effect on A-MLV 
internalization.  Similarly to the previous observations, the results demonstrated increase in viral 
infection in presence of bovine lactoferrin, and A-MLV infection was further enhanced as the 
concentration of bovine lactoferrin increased from 100 to 400 µg/ml (Fig. 37). Viral infectivity 
decreased in presence of amiloride and EIPA and water did not seem to interfere with the viral 
uptake observed in presence of bovine lactoferrin (Fig. 37).   
 
Figure 37. The effect of different concentrations of bovine lactoferrin on A-MLV lacZ infection in A31 
wt cells. The cells were incubated with 100 µg/ml and 400 µg/ml BLF for 5 hours in presence of equal 
amounts of A-MLV lacZ virus, after which the inoculum was removed and fresh culture medium was added 
to the cells for an additional 24 hours incubation to allow lacZ transcription. In parallel cells were treated 
with peptide (100 µg/ml ), virus and macropinocytosis inhibitors and their absorption values are shown in 
purple and blue for amiloride and EIPA respectively. Absorption value of cell that received water and virus 
in the same manner as peptides and virus the only difference being the peptide is shown in orange. The viral 
infectivity was quantitatively measured by ONPG assay as described in the Materials and Methods section. 
The negative control (absorption of uninfected cells) is subtracted from all the absorption values.  Data 
represent mean and SEM of sets of 2 individual experiments (except for data from one experiment including 
the water effect). 
Lactoferricin B was used in limited number of experiments due to the cost of the same; therefore 
studies including LfcinB and macropinocytosis inhibitors were not conducted. However, the results 
show an obvious increase on A-MLV lacZ infection in presence of lactoferricin B (Fig. 38). 
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Figure 38. The effect of lactoferricin B on A-MLV lacZ infection in A31 wt cells. The cells were 
incubated with 250 µg/ml lactoferricin B for 5 hours in presence of equal amounts of A-MLV lacZ virus, 
after which the inoculums were removed and fresh medium added to the cells for an additional 24 hours 
incubation to allow lacZ transcription. The viral infectivity was quantitatively measured by ONPG assay as 
described in the Materials and Methods section. The negative control (absorption of uninfected cells) is 
subtracted from all the absorption values. Lactoferricin B increases the susceptibility of A31 wt cells to A-
MLV lacZ infection.  Data represent mean and SEM of 2 individual experiments. No further experiments 
were performed with this peptide due to the high cost of the same. 
 
It had been previously established that cells overexpressing PiT-2 receptor are more susceptible to 
A-MLV infection. During the ONPG method development, to gain higher readings, A31 wt cells 
overexpressing human PiT-2 were established (A31 (h) PiT-2) by stably transducing them with 
ecotropic murine leukemia virus (E-MLV) that carried the human PiT-2 vector. We used these cells 
to primarily test for the degree of A-MLV lacZ infection in A31 wt and A31 (h) PiT-2 cells. The 
results demonstrated that A31 wt and A31 (h) PiT-2 cells gave significantly different viral titers 
when quantified using the ONPG assay (Fig. 39A). Similar results were demonstrated using the 
lacZ expression system staining A-MLV infected cells blue in the presence of X-gal (Fig. 39B). 
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Figure 39. A-MLV lacZ infection in A31 wt and (h) PiT-2 A31 cell lines. A) A31 wt and A31 (h) PiT-2 
cells were seeded in a 96-well plate and incubated ~24  hours with different viral titers, followed by a day of 
incubation in fresh medium to allow expression of lacZ gene. B) In parallel with the ONPG assay, the X-gal 
assay was used to visualize A-MLV lacZ infected cells (stained blue). C) Data represents the mean and SEM 
from three individual experiments. 
A31 (h) PiT-2 cells were used to further validate the peptide interference in A-MLV lacZ infection. 
Through a limited number of experiments the overall increase of viral internalization was 
maintained. These results are summarized in figure 40, where the absorption of the cells treated 
with virus only was subtracted from the absorption values of the cells treated with both peptide and 
virus. The results demonstrate an increase in A-MLV infection in A31 (h) PiT-2 cells by LL-37, 
BLF and most profoundly by 1018 (Fig. 40).  
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Figure 40. LL-37, BLF and 1018 stimulate A-MLV lacZ infection in A31 (h) PiT-2 cells. The cells were 
incubated with 30 µg/ml LL-37, 100 µg/ml BLF and 100 µg/ml 1018 for 5 hours in presence of equal 
amounts of A-MLV lacZ virus, after which inoculum was removed and fresh medium added to the cells for 
an additional 24 hours incubation to allow lacZ transcription. The viral infectivity was quantitatively 
measured by ONPG assay as described in the Materials and Methods section. The negative control 
(absorption of uninfected cells) is subtracted from all the absorption values. No considerable change of A-
MLV infection is observed by LL-37, however increase in viral infection is significantly observed in 
presence of BLF and 1018. Data represent mean and SEM from two individual experiments.  
 
5.6  Peptide affinity to heparan- and chondroitin sulfate by affinity chromatography 
 
To investigate the correlation of peptide binding to heparan- and chondroitin sulfate to the 
activity they pose in the viral assays, the affinity of LL-37, bovine lactoferrin,  bovine lactoferricin, 
1018 peptides was studied by affinity chromatography. Nisin A and propranolol affinities were also 
analyzed. The results from the heparan– and chondroitin sulfate affinity studies are presented in 
Table 5. LL-37 exhibits the highest affinity to heparan sulfate after which bovine lactoferrin, 
lactoferricin B, 1018 and nisin A follow. In general, all of the peptides show higher affinity to 
heparan sulfate than chondroitin sulfate.   
Table 5. Affinity of various peptides and propranolol to heparan- and chondroitin sulfate as studied by 
affinity chromatography 
                           column 
peptide 
Chondroitin sulfate  
retention times tr and  mM 
NaCl 
Heparan sulfate  
retention times tr and  
mM NaCl 
 
LL-37 
 
Not analyzed 
 
23.49 min – 524 mM 
Bovine lactoferrin 
(BLF) 
 
13.2 min – 251 mM 
 
17.9 min – 369 mM 
Bovine Lactoferricin 
(LfcinB) 
 
8.73 min – 158 mM 
 
15.2 min – 313 mM 
 
1018 synthetic 
 
5.96 min - 108 mM 
 
13.2 min – 272 mM 
 
NisinA 
 
elutes before the gradient 
starts 
 
7.5 min – 125 mM 
Propranolol elutes before the gradient 
starts 
Not analyzed 
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5.7  Capillary electrophoresis frontal analysis  
 
The experiments were performed in 0.067 M phosphate buffer (high ionic strength in order to 
reduce the adsorption of the peptides to the capillary wall (Walbroehl and Jorgenson 1989) at pH 
7.4,  commonly used in binding studies. The initial experiments regarding capillary electrophoresis 
frontal analysis were conducted using propranolol as a cationic model compound. Propranolol 
carries one positive charge at the working pH of 7.4 and therefore as positive specie appears first in 
the electropherogram (Fig. 41). 0.1 % DMSO is used as a neutral marker for monitoring the 
electroosmotic flow of the signals (Fig. 41). In practice the first choice of capillary is the uncoated 
bare-fused silica capillary. However for the peptide analysis differently coated capillaries are 
recommended and therefore applied in this study.  
 
Figure 41. Electropherogram of sample containing 500 µM propranolol and 0.1 % DMSO for EOF 
detection. DMSO is a neutral marker that will migrate after any positively charged specie, in this case 
propranolol. Conditions: Uncoated silica fused capillary (31.2 cm  50µm ID, 20 cm to the detector ); 
applied voltage 8 kV; detection at 214 nm; hydrodynamic injection for 30 sec (0.5 psi); instrument 
temperature 25
°
C. 
 
5.7.1 Ligand-Chondroitin Sulfate Complexation 
 
5.7.1.1 Propranolol-Chondroitin sulfate complexation 
 
In order to obtain binding isotherms for the low-molecular weight ligand, propranolol and 
chondroitin sulfate complexation using capillary electrophoresis frontal analysis, initially a standard 
curve was made where samples containing different propranolol concentrations were injected in the 
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capillary (Fig. 42). To obtain FA conditions, injection of a large sample plug is needed. Afterwards, 
samples containing different propranolol concentrations, ranging from 25 to 400 µM, but the same 
chondroitin sulfate concentration (25 mg/ml, corresponding to 0.52 x 10
-1 
M
 
when the repeating unit 
of bovine cartilage chondroitin sulfate is assumed to have molecular formula C14H20NNaO14S) were 
analyzed by the same methodology. As a result of charge difference of the molecules in the sample, 
propranolol, carrying one positive charge at the working pH, gave the first plateau peak after about 
2.5 min (Fig. 43). In the CE-FA due to large sample volumes, during the separation the equilibrium 
is maintained in the overlapping zones containing both the cationic compound and chondroitin 
sulfate (Fig. 18). The height of the plateau peak was measured and using the linear regression from 
the standard curve, the free propranolol concentration in each of the samples was calculated. 
Complexation between the chondroitin sulfate and propranolol is clearly observed from the 
decrease in plateau peak heights (peaks, 4, 5 and 6 compared with 1, 2 and 3 in Fig. 43) and 
broadening of the propranolol peaks in the samples relative to the standards. The peaks from 
chondroitin sulfate and the complex are not observed in the electropherograms in figure 43. 
 
Figure 42. Propranolol standard curve. Propranolol standard samples within (25-400 µM) concentration 
range were prepared and analyzed by CE-FA to obtain standard curve. Using linear regression the 
concentration of free propranolol in the samples containing chondroitin sulfate can be determined.  
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Figure 43. Electropherogram showing overlay of multiple signals obtained from samples containing 
propranolol and propranolol-chondroitin sulfate complexation studied by CE-FA. Signals 1, 2 and 3 
correspond to 200 µM, 150 µM and 100 µM of total propranolol concentration in the standard samples 
respectively. Broader signals 4, 5 and 6 corresponding to 200 µM, 150 µM and 100 µM with 25 mg/ml 
chondroitin sulfate respectively are shown. Conditions: Uncoated silica fused capillary (31.2 cm  50 µm ID, 
20 cm to the detector ); applied voltage 8 kV; detection at 214 nm; hydrodynamic injection for 30 sec (0.5 
psi); instrument temperature 25
°
C. 
For the data analysis and construction of binding isotherm to determine the apparent association 
constant Kapp, the information from chapter 3.8.4 was applied. The binding isotherm for propranolol 
and chondroitin sulfate complexation depicting binding density, v as a function of free propranolol 
concentration (Fig. 44) is linear. The current CE-FA study analyses cover the lower part of the 
propranolol-chondroitin sulfate isotherm as seen from the v being less than 0.01. For v approaching 
zero, it is known that the binding equation  written in the introductory chapters (Eq. 10), reduces to 
v/[L]free=Kapp (Ostergaard, Khanbolouki et al. 2004), thus the apparent association constant, Kapp is 
determined from the slope of the binding isotherm, and equals 21.9 M
-1
. This value agrees with  
association constant for propranolol-chondroitin sulfate complexation found in the literature (2 M
-1
) 
(Ostergaard, Larsen et al. 2009). 
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Figure 44. Binding isotherm of propranolol obtained by CE-FA. The slope of the binding isotherm gives 
the apparent association constant, Kapp, which is 21.9 M
-1
 for propranolol. 
 
5.7.1.2 NisinA-Chondroitin sulfate complexation 
 
After establishing a binding constant for the low-molecular-weight ligand and chondroitin 
sulfate complexation, the new experiments were aiming to analyze somewhat more complicated 
systems involving high-molecular-weight ligands carrying more than one positive charge (see 
Appendix 3 for net charges for all peptides), namely peptides and chondroitin sulfate. The idea 
behind the CE experiments was to see whether the more positively charged peptides bind to 
chondroitin sulfate with greater affinity than propranolol. However during the method development, 
difficulties during the peptide analysis were met making the interpretation of the results 
challenging. 
 The initial experiments involved nisin A, as one of the least charged among the rest of the peptides 
included in this study.  NisinA standard solutions (30-200 µM) were prepared from 0.5 mM stock 
solution, in 67 mM phosphate buffer, pH 7.4.  Nisin A standards were introduced into the long end 
(20 cm to the detector window of 31.2 cm total length of the capillary) of the uncoated silica fused 
capillary by pressure (0.5 psi) with duration of 30 sec. Irregular peak shapes were observed for 
several samples containing different nisin A concentrations (Fig. 45).   The heights of the first and 
second plateaus were measured. However the reproducibility of the irregular peak shapes for 
different concentration was not maintained accurate in day to day experiments and posed problems 
whenever higher concentration of nisin A (>400 µM ) was injected in the capillary. 
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 Therefore few points were obtained for the nisin A standard curve.  In addition to the uncoated 
silica fused capillary, nisin A was run through PVA coated capillary. PVA capillaries are 
permanently coated with highly hydrophilic poly (vinyl alcohol) and can decrease peptide/protein 
adsorption. However this did not improve nisin A peak shape and due to the absence of the EOF, 
the signal appeared around 25 min (data not shown). Therefore, uncoated silica fused capillary was 
chosen for the further analysis.  
 
Figure 45.  Different nisin A concentrations injected in uncoated silica fused capillary with duration of 
30 sec. Single, well defined plateau peak was not observed from the injected standard sample containing 
Nisin A only.  Therefore the heights of the first and second peak were measured, as indicated. Conditions: 
Uncoated silica fused capillary (31.2 cm  50 µm ID, 20 cm to the detector ); applied voltage 8 kV; detection 
at 214 nm; hydrodynamic injection for 30 sec (0.5 psi); instrument temperature 25
°
C. 
For separation purposes of signals from multiple species present in a mixture, shorter injection 
times are applied. Therefore, nisin A standard sample was introduced in the uncoated silica fused 
capillary with duration of 3 sec. Two distinct signals were observed as shown in figure 46.   Next, 
before addition of chondroitin sulfate to nisin A, chondroitin sulfate (25 mg/ml) standard sample 
was introduced in the uncoated silica fused capillary. Chondroitin sulfate is a long polymer that 
carries net negative charge at physiological pH; therefore the signal is expected to be observed after 
long running time. However, signal from chondroitin sulfate standard sample was observed at 
around 4 min from a total sample run of 30 min. This signal overlapped with the second peak from 
the nisin A standard sample (Fig. 46).   
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Figure 46. Showing separation of impurities or trace components present in the nisin A standard 
sample and a signal from chondroitin sulfate standard sample. Both samples were injected with duration 
of 3 sec in uncoated silica fused capillary. The second peak from nisin A standard sample  (200 µM) 
overlaps signal with the signal obtained from chondroitin sulfate standard sample (25 mg/ml Conditions: 
Uncoated silica fused capillary (31.2 cm  50 µm ID, 20 cm to the detector); applied voltage 8 kV; detection 
at 214 nm; hydrodynamic injection for 3 sec (0.5 psi); instrument temperature 25
°
C. 
To determine whether the signal observed from chondroitin sulfate analysis comes from a 
positively, negatively charged or neutral compounds, 0.1 % DMSO was added to the sample 
containing 25 mg/ml chondroitin sulfate and analyzed. Using only 3 sec injection time, no 
separation was observed for the sample containing both chondroitin sulfate and DMSO, pointing 
out that the signal comes from some neutral impurity in the chondroitin sulfate itself. Moreover, the 
signal overlapped with the signal from the sample containing 0.1 % DMSO only (Fig. 47). 
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Figure 47. Impurity nature detection in chondroitin sulfate standard sample. Chondroitin sulfate 
standard solution (25 mg/ml) in phosphate buffer containing 0.1 % DMSO was injected into the uncoated 
silica fused capillary for 3 sec duration. Since chondroitin sulfate carries net negative charge the EOF is not 
detected within 30min of analysis (total run time of 30min is not shown). However a peak appearing around 
4.5 min caused signal overlapping with nisin A and therefore the EOF of the impurity were determined using 
DMSO as a neutral EOF marker. The chondroitin sulfate,-DMSO containing sample and DMSO peaks 
overlap pointing out that the impurity observed in the chondroitin sulfate is from a neutral character. 
Uncoated silica fused capillary (31.2 cm  50 µm ID, 20 cm to the detector ); applied voltage 8 kV; detection 
at 214 nm; hydrodynamic injection for 3 sec (0.5 psi); instrument temperature 25
°
C. 
 
Next, a sample containing nisin A - chondroitin sulfate pre-equilibrated mixture was introduced 
from the longer end of the uncoated capillary in the same fashion as the nisin A standard samples. 
Decrease in the first peak heights as expected was observed upon addition of chondroitin sulfate 
when compared with the standards. The signal from the nisin A-chondroitin sulfate mixture 
overlapped with the second peak from the nisin A standard sample and with the signal from the 
chondroitin sulfate standard sample as shown in figure 48. According to the above stated 
observations, the height of the first plateau peak in nisin A standard samples appears before DMSO 
and chondroitin sulfate signals indicating a signal from a positively charged specie, nisin A.   
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Figure 48. Shown peaks from nisin A (50 µM) with and without chondroitin sulfate (25 mg/ml) and 
chondroitin sulfate (25 mg/ml) only. Decrease in the first “plateau peak” is observed as a result of nisin A 
and chondroitin sulfate complexation. No signal interference of chondroitin sulfate with the first peak of 
nisin A is observed, since chondroitin sulfate signal appears around 3.6 min. Conditions: Uncoated silica 
fused capillary (31.2 cm  50 µm ID, 20 cm to the detector); applied voltage 8 kV; detection at 200 nm; 
hydrodynamic injection for 30 sec (0.5 psi); instrument temperature 25
°
C.  
 
In addition to the measurements shown above, injection of the samples from the short end of the 
capillary (11 cm to the detector window of 31.2 cm total length of the capillary) was performed. 
This provides shorter analysis time and lowers the possibility of peptide adsorption to the capillary 
wall that may interfere with the analysis. Initially a series of nisin A standard sample injections with 
different duration times (5, 8, 12, 20 and 30 seconds) was carried out. The irregular peak shape was 
still retained, but this time no defined plateau peaks could be seen (Fig. 49). Using the short end 
injection method, injections for duration of 12 seconds were chosen for the further analysis. A 
series of nisin A standard solutions were analyzed where the height of the first peak was measured 
and used for constructing calibration curve (Fig. 52). Analysis of samples containing nisin A and 
chondroitin sulfate followed next. Irregular peak shapes were observed however distinguished first 
plateau signals corresponding to nisin was present. This signal decreased upon chondroitin sulfate 
addition (Fig. 50).   
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Figure 49. Different time injections effect on the peak shape of nisin A (150 µM) sample injected from 
the short end of the capillary. Short end analyses allow faster peak detection but are less efficient in peak 
separation. Irregular peak shapes with no well defined plateau are observed. Conditions: Uncoated silica 
fused capillary (31.2 cm  50 µm ID, 11 cm effective length); applied voltage 8 kV; detection at 200 nm; 
hydrodynamic injection for 5, 8, 12, 20 and 30 sec (0.5 psi); instrument temperature 25
°
C.  
 
Figure 50. Complexation of nisin A and chondroitin sulfate as studied by CE-FA.  Nisin A (100 µM) 
was injected from the short end of the capillary for duration of 12 seconds. The primary signal shows nice 
plateau which decreases upon chondroitin sulfate addition as a result of nisin A-chondroitin sulfate 
complexation. Conditions: Uncoated silica fused capillary (31.2 cm  50 µm ID, 11 cm effective length); 
applied voltage 8 kV; detection at 200 nm; hydrodynamic injection for 12 sec (0.5 psi); instrument 
temperature 25
°
C. 
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Chondroitin sulfate sample was analyzed from the short end of the capillary. No signal interference 
is observed in the nisin A peak region. The impurity of chondroitin sulfate appears after 1.5 min of 
analysis and overlaps with the second peaks of nisin A standard sample and nisin A-chondroitin 
sulfate complexation sample (Fig. 51).  
 
Figure 51. Complexation of nisin A and chondroitin sulfate as studied by CE-FA. In addition to nisin A 
(200 µM) signal and nisin A-chondroitin sulfate complexation, chondroitin sulfate (25 mg/ml) signal is 
shown. A decrease in the first peak height is observed as a result of nisin A-chondroitin sulfate 
complexation. Chondroitin sulfate standard sample does not give signal that overlaps with the first peak 
height of nisin A standard sample and nisin A –chondroitin sulfate containing sample. Conditions: Uncoated 
silica fused capillary (31.2 cm  50 µm ID, 11 cm effective length); applied voltage 8 kV; detection at 200 
nm; hydrodynamic injection for 12 sec (0.5 psi); instrument temperature 25
°
C. 
As previously observed, chondroitin sulfate standard sample contains impurity which signal appears 
after nisin A primary signal and therefore does not interfere with the measurements regarding the 
complexation of nisin A and chondroitin sulfate. The height of the plateau peak was measured and 
using the linear regression from the standard curve, the free nisin A concentration in each of the 
samples was calculated. Nisin A standard curve was obtained from the short end injection due to the 
consistency of the signals and ability to measure different concentrations without much of a 
difficulty (Fig. 52).  
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Figure 52.  Nisin A standard curve. Nisin A standard samples within (75-300 µM) concentration range 
were prepared and analyzed by CE-FA to obtain the standard curve. Using linear regression the 
concentration of free nisin A in the samples containing chondroitin sulfate can be determined.  
Using the same principle of determining the apparent association constant for propranolol, nisin A-
chondroitin sulfate binding constant was calculated. The binding isotherm and association constant 
was calculated to be 49.8 M
-1
 (Fig. 53). 
 
Figure 53. Binding isotherm of nisin A and chondroitin sulfate obtained by CE-FA. Interaction of nisin 
A and chondroitin sulfate (25 mg/ml) in 67 mM phosphate buffer (pH 7.40) at 25
°
C. The apparent 
association constant, Kapp for nisin A and chondroitin sulfate complexation is 49.8 M
-1
. 
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5.7.1.3 Lactoferricin B -Chondroitin sulfate complexation 
 
Bovine lactoferricin carries eight positive charges at physiological pH (table 9, Appendix 3). 
From a series of difficulties met during the analyses in various types of capillaries, few 
representative data are shown for lactoferricin B. The peptide was initially analyzed on uncoated 
silica fused capillary. Irregular peak shapes were also observed with this peptide as with nisin A. 
Polycations adsorption to the capillary wall is evident by a lack of return of the baseline to zero, 
after peak passage (Ermakov, Zhukov et al. 1995). This has been observed for lactoferricin B on the 
uncoated silica fused capillary (Fig. 54). Different lactoferricin B standard samples were injected in 
the uncoated silica fused capillary with duration of 30 seconds. Due to the appearance of multiple, 
not well defined peaks no measurements of peak heights could be obtained. The peaks shapes are 
illustrated in figure 54.  
 
Figure 54. Electropherogram of different lactoferricin B standard solutions. 1)100 µM, 2) 150 µM, 3) 
200 µM, 4) 250 µM. Irregular peak shape signals were observed as the concentration of lactoferricin B was 
increased. Strong adsorption to the capillary wall as a result of lack of return of the baseline to zero is 
observed. Conditions: Uncoated silica fused capillary (31.2 cm  50 µm ID, 20 cm to the detector); applied 
voltage 8 kV; detection at 200 nm; hydrodynamic injection for 30 sec (0.5 psi); instrument temperature 25
°
C. 
 
After different lactoferricin B standard samples were run on the uncoated silica fused capillary, in 
order to see which peaks would eventually decrease upon chondroitin sulfate addition, samples 
containing mixture of lactoferricin B and chondroitin sulfate were measured. Unfortunately, before 
any signals were obtained, a failure of the capillary occurred. Therefore, lactoferricin B 
measurements were carried on a new uncoated silica fused capillary with injection from the short 
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end and on PVA coated capillary. Lactoferricin B peaks could be observed within the first 2 
minutes in the short end injection method when compared with the long end injection method where 
the peaks appeared after about five and half minutes. The short end analysis also confirmed multiple 
peaks to be present in the lactoferricin B standard samples. This could be clearly seen from the 
peaks shape, when lactoferricin B standard samples were introduced in the capillary with duration 
of 12 sec compared with the sample introduced with duration of 30 sec (Fig. 55).  
 
Figure 55. Separation of multiple peaks present in lactoferricin B standard sample. Lfcin B (100 µM) 
was injected from the short end of the uncoated silica fused capillary for 30 sec and 12 sec. Better peak 
separation is observed with 12 sec duration. Conditions: Uncoated silica fused capillary (31.2 cm  50 µm 
ID, 11 cm effective length ); applied voltage 8 kV; detection at 200 nm; hydrodynamic injection for 30 sec 
and 12 sec (0.5 psi); instrument temperature 25
°
C.  
Even though no measurements could be taken for any peak height, a mixture of lactoferricin B and 
chondroitin sulfate was introduced from the short end of the uncoated silica fused capillary and the 
signal can be seen in figure 56. There is a comparable decrease observed when the signals from the 
lactoferricin B standard and the sample (containing the mixture) are evaluated.  However the 
absence of well defined plateau peaks that could be distinguished from any other signals that could 
interfere the measurements was not achievable and therefore no further measurements could be 
done on the uncoated silica fused capillary. The alternative possibility of analyzing lactoferricin B 
on PVA coated capillary did not appear to be successful either and resulted in longer detection time 
(t > 12 min) without defined peak shape (Fig. 57). The signals from running different lactoferricin 
B concentrations were not consistent and adsorption to the capillary wall was also present as higher 
lactoferricin B concentrations were introduced in the capillary. As soon as the mixture of 
lactoferricin B and chondroitin sulfate was applied to the PVA coated capillary, the capillary was 
 76 
 
damaged before any signal appeared, and this could be deduced from the instability of the current 
during the analysis.  
 
Figure 56. Complexation of lactoferricin B and chondroitin sulfate as studied by CE-FA. Lactoferricin 
B (100 µM) standard sample was injected from the short end of the uncoated silica fused capillary with 
duration of 30 sec. A mixture of lactoferricin B and chondroitin sulfate was introduced by the same 
procedure. Overall decrease in the signal from the lactoferricin B-chondroitin sulfate containing sample can 
be observed when the two signals are compared as a result of lactoferricin B-chondroitin sulfate 
complexation. However, this complexation could not be quantified. Conditions: Uncoated silica fused 
capillary (31.2 cm  50 µm ID, 11 cm effective length ); applied voltage 8 kV; detection at 200 nm; 
hydrodynamic injection for 30 sec (0.5 psi); instrument temperature 25
°
C. 
 
Figure 57. Electropherogram of lactoferricin B on PVA coated capillary. Lactoferricin B (200 µM and 
150 µM) was introduced on PVA coated capillary in order to decrease the adsorption phenomena. However 
even though the signal from 150 µM looked promising, it is not consistent with the signal from 200 µM 
lactoferricin B standard sample. Strong adsorption is observed for the 200 µM lactoferricin B in addition to 
the irregular shape peak. In addition it was difficult to reproduce the same data. Conditions: PVA coated 
capillary (31.2 cm  50 µm ID, 20 cm to the detector); applied voltage 8 kV; detection at 200 nm; 
hydrodynamic injection for 30 sec (0.5 psi); instrument temperature 25
°
C. 
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Bovine lactoferrin, which is highly positively charged at physiological pH, was run on the uncoated 
silica fused capillary. Even thought the sample was run for long time of up to 40 min, only signal 
from neutral specie could be detected within the 4
th
 minute of analysis (data not shown). No further 
experiments were performed using bovine lactoferrin.  
Surfactants at concentrations below the critical micelle concentration are widely used as buffer 
additives in order to compete for capillary surface wall adsorption. Non-ionic TWEEN 20 surfactant 
below 0.0054 % (below CMC) was applied in order to improve the peptides signals. The peptide 
signals did not improve significantly (data not shown). However the surfactant could not be used for 
the direct studies when chondroitin sulfate is applied due to the possible interaction of the surfactant 
and chondroitin sulfate. Surfactants can also change the charged state of the capillary surface and 
thus change the overall electroosmotic flow which can be increased, reduced, or reversed.  
A summary of the capillaries used for peptide analysis in the present study and the success in 
obtaining good results is summarized in table 6.   The determined Kapp –values of propranolol and 
nisin A with chondroitin sulfate are provided in table 7. 
Table 6. Summary of capillaries used for different peptides/protein and propranolol 
peptide capillary Results 
Nisin A PVA None 
 Neutral  None 
 Uncoated silica 
fused 
OK 
                                      CEP coated None 
LfcinB Uncoated silica 
fused 
None 
 PVA Not reliable 
BLF Uncoated silica 
fused 
Neutral species 
observed  
 PVA None 
Propranolol Uncoated silica           
fused 
OK 
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Table 7. Apparent dissociation constants (Kapp) determined by Capillary Electrophoresis Frontal 
Analysis in 0.0067 M phosphate buffer pH 7.4 at 25
°
C. 
compound  Kapp (M
-1
) 
Propranolol 21.9 
Nisin A 49.8 
 
6. Discussion 
 
The study of viruses is important for medical reasons and studies about pathogen entry in 
general have taught us about a great deal of cellular trafficking etc. In this study, we have examined 
the mechanism of A-MLV entry in different cell models with focus on the use of macropinocytosis. 
By a series of experiments, we have attributed to the A-MLV use of macropinocytosis for infection 
of mouse fibroblasts and human epithelial cells.  
6.1  Macropinocytosis characterization 
 
The most effective fluid-phase uptake process in cells occurs via macropinocytosis. 
Macropinocytosis can be a constitutive process in many cells types while in others it is triggered by 
growth factors receptor interactions (Swanson and Watts 1995). Various pathogens including 
bacteria and viruses can induce the membrane ruffling independently of growth factors and as a 
result they can be internalized together with the fluid uptake. The first approach to verify the 
activity of macropinocytosis in A31 wt and NIH 3T3 cells was to use macropinocytosis markers. 
Dextran dye conjugates are taken up by cells via fluid-phase endocytosis and have been widely used 
to establish the contribution of macropinocytosis to viral uptake such as in cases of bluetongue 
virus-1 (Gold, Monaghan et al. 2010), adenovirus type 35 (Kalin, Amstutz et al. 2010), vaccinia 
virus (Sandgren, Wilkinson et al. 2010) etc. Live cell imaging demonstrated that dextran is 
internalized after 4 hours indicating active macropinocytosis in the representative cells. 
Macropinocytosis is sensitive to amiloride and EIPA treatments therefore these inhibitors are often 
used to identify macropinocytosis. Amiloride and EIPA affect the Na
+
/H
+
 exchangers thus elevating 
the cytosolic pH and stimulating Na
+
 influx. These changes can alter signaling pathways involved 
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in cytoskeleton rearrangement and therefore influence macropinocytosis (Koivusalo, Welch et al. 
2010). Indeed, 70 kDa dextran uptake was inhibited in presence of amiloride (Fig. 23).  
A-MLV internalization has been studied by multiple research groups, where various entry 
routes have been proposed. A-MLV internalization via direct fusion with the plasma membrane    
(McClure, Sommerfelt et al. 1990), receptor mediated entry (Katen, Januszeski et al. 2001) and 
caveolae-dependent entry has been reported (Beer, Andersen et al. 2005). Later experiments 
showed that caveolin knock out mouse fibroblast cells show higher A-MLV infection when 
compared with the wild type cells together with additional experiments, a caveolae-independent 
entry route is proposed (Moneva, Vilhardt, data not published). Our present results demonstrate the 
use of macropinocytosis by A-MLV for infection of targeting cells.   
6.2  Susceptibility of four different cell types to A-MLV infection 
 
The conducted series of flow cytometry experiments revealed the infection degree in four 
different cell types. Cells differed in their susceptibility to A-MLV with A31 wt cells being the 
most susceptible. This difference might be as a result of different levels of PiT-2 receptor 
distributions or in the degree of active macropinocytosis in the cells. Our findings indicate a 
decrease in A-MLV infection in all cell types in presence of amiloride and EIPA (Fig. 26). 
Although there is a difference in the percentage of the cell infected with A-MLV which varied due 
to different viral productions, the decrease of viral infection in presence of amiloride and EIPA was 
retained in all experiments. In order to verify the effects of amiloride on macropinocytosis, VSV 
vector was used. Vesicular stomatitis virus enters the cells via clathrin-mediated endocytosis (Sun, 
Yau et al. 2005), and amiloride does not affect this endocytic pathway (West, Bretscher et al. 1989). 
Therefore our results show that VSV internalization in presence of amiloride is not inhibited but 
slightly increased depending on the cell lines. In A31 wt and NIH 3T3 cells, VSV infection was not 
affected by amiloride to a higher extent (Fig. 27-28). In contrary HeLa cells were highly susceptible 
to VSV infection and infection was inhibited in presence of amiloride and EIPA (Fig. 31). VSV 
infection in HCT-116 cells was increased when the cells were treated with amiloride and was not 
significantly changed in presence of EIPA (Fig. 31). However, this observation is consistent with 
the idea that even though one general pathway can be established in a specific cell line for a specific 
virus, various other routes can be exploited by the virus for successful infection in different cell 
types. Such is the case of poliovirus which internalization in HeLa cells occurs via clathrin-, 
caveolin-independent and actin-dependent pathway (Brandenburg, Lee et al. 2007) whereas in 
human brain microvascular endothelial cells poliovirus entry is via caveolae-dependent endocytosis 
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(Coyne, Kim et al. 2007). Influenza virus, herpes simplex virus and vaccinia virus are among the 
other viruses that make use of multiple pathways to enter different cell types (Sieczkarski and 
Whittaker 2002; Nicola and Straus 2004; Clement, Tiwari et al. 2006). 
6.3  PiT-2 is not localized in the lipid rafts 
 
Entry of A-MLV into target cells is mediated by binding to PiT-2 (Feldman, Farrell et al. 
2004). Overexpression of PiT-2 results in higher infectivity (Fig. 39). This finding together with the 
established role of macropinocytosis in A-MLV internalization indicates that the A-MLV 
internalization is specific and A-MLV is not randomly taken up with the rest of the extracellular 
fluid. In addition, most of the PiT-2 receptor was extracted by 1% Triton X-100 at 4
°
C, indicating 
that PiT-2 is not localized in the lipid rafts of the plasma membrane which are specific plasma 
membrane domains where caveolae-dependent entry occurs (Fig. 32).   
Despite the limited experimental attempts in defining macropinocytosis as an entry route of A-
MLV in mouse fibroblast and human epithelial cell (6.1-6.3), there are other methods used to 
validate macropinocytosis, one of which is the use of different specific inhibitors (e.g, wortmannin, 
LY294002 or cytochalasin D) (Xu, Ziemnicka et al. 2000; Falcone, Cocucci et al. 2006). 
6.4  Peptide interference with A-MLV internalization 
 
To test the effect on antimicrobial peptides on A-MLV internalization, LL-37, lactoferricin B, 
bovine lactoferrin and 1018 were investigated in viral assays. Their antimicrobial property had been 
previously described against bacteria and viruses (Gordon, Huang et al. 2005; Jenssen, Hamill et al. 
2006), except 1018 whose antiviral property has not been described in the literature. All of the 
investigated peptides exhibited pro-viral activities, stimulating A-MLV uptake in the representative 
cells. Even though the viral ONPG assay showed low sensitivity in most of the experiments, there 
was a consistency in the observed effects of the peptides on A-MLV internalization. The synthetic 
peptide 1018 stimulated A-MLV internalization in a concentration dependent manner, resulting in 
higher infection as the peptide concentration increased (Fig. 33). The same was observed for 
lactoferricin B and bovine lactoferrin. However this was not the case for LL-37 where different 
concentration ranges gave different results, even though the overall increase of A-MLV intake was 
sustained. The peptides have been originally dissolved in water and prediluted in medium prior to 
use. However to exclude the possibility that even a minor change in the medium (up to 5 % more 
water in the medium than in the controls) may contribute to stimulation of fluid phase uptake by the 
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cells, the water effect on viral uptake was also analyzed. The results indicate that the increased A-
MLV infection is mainly due to LL-37, bovine lactoferrin and 1018 effects on the cell or on the 
virus. All in all, these observations lead to speculate peptide internalization and the possibility of 
the peptides to upregulate macropinocytosis or interact with the viral envelope or the host cell 
membrane. 
6.4.1 Peptide internalization by macropinocytosis 
 
It is postulated that, the net positive charge of a peptide at the physiological pH, together with 
the peptide secondary structure are the determining factors for peptide internalization. Moreover it 
has been reported that many arginine-rich peptides efficiently internalize into cells, and the number 
of arginine residues is important for this internalization (Nakase, Hirose et al. 2009). In the present 
studies the peptides used in the viral assays have up to 5 arginine residues and carry net positive 
charge of 7, 6 and 4 for lactoferricin B, LL-37, and 1018, respectively except for bovine lactoferrin 
protein that has greater number of arginine residues and much higher net charge (table 9, Appendix 
3). The rapid interaction as a result of strong electrostatic interactions between the, negatively 
charged species such as the cell membrane associated proteoglycans, and the positively charged 
peptides is assumed to be the first step in peptide internalization (Ziegler and Seelig 2004). 
Understanding how peptides interact with sulfated polysaccharides on the cell surfaces, provides an 
insight into their internalization. The importance of the cell surface proteoglycans in peptide entry 
has been reported in several studies (Bernfield, Gotte et al. 1999; Fuchs and Raines 2004; Richard, 
Melikov et al. 2005; Nakase, Tadokoro et al. 2007; Kosuge, Takeuchi et al. 2008). Some of the 
studies show that mutant cell lines, defective in proteoglycans biosynthesis, result in lower peptide 
adsorption on the cell surfaces (Kosuge, Takeuchi et al. 2008) pointing out the contribution of 
recruitment of peptides by cell surface proteoglycans. In another study, addition of sulfated 
polysaccharides to the cells in presence of peptides, showed decreased peptide adsorption (Nakase, 
Hirose et al. 2009). The peptide uptake mechanisms vary from diffusion across the cell membrane 
which is peptide concentration dependent (Kosuge, Takeuchi et al. 2008), to peptide internalization 
by macropinocytosis (Jones 2007).  Macropinocytosis has been suggested as the internalization 
route for cellular uptake of the arginine-rich peptides and induction of the same is an essential part 
of the uptake (Nakase, Niwa et al. 2004; Wadia, Stan et al. 2004; Kaplan, Wadia et al. 2005; 
Nakase, Tadokoro et al. 2007). Macropinocytosis inhibitors are used to evaluate the role of 
macropinocytosis in peptide entry. A significant suppression in the cellular uptake of flock house 
virus (FHV) coat peptide in presence of EIPA has been observed. In addition, cellular uptake of the 
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macropinocytotic marker, FITC-labeled dextran (70 kDa), has been demonstrated to increase in 
presence of the same peptide. In GAG deficient cells, FITC-dextran enhanced uptake had not been 
observed in presence of FHV peptide (Nakase, Hirose et al. 2009). Due to limited availability and 
the cost of the working peptides, only macropinocytosis inhibitors have been included for the 
purpose of investigating the possible cellular entry of LL-37, lactoferricin B, bovine lactoferrin and 
1018 by macropinocytosis. Our data from the ONPG assay showed inhibition is of peptide-
stimulated A-MLV infection in the presence of amiloride and EIPA (Fig. 36). In correlation to the 
peptides in this study, human lactoferrin internalization has been elucidated and several 
internalization processes have been proposed ranging from receptor induced endocytosis using a 
specific lactoferrin receptor (LfR) characterized in several mammalian cell lines (Birgens, Hansen 
et al. 1983) and/or energy independent entry mediated through the lactoferrin N-terminal region 
G1RRRR5 identified as nuclear localization signal (NLS) (Penco, Scarfi et al. 2001). Lactoferricin B 
can be internalized in an energy independent way (Andersen, Jenssen et al. 2004) and 1018 
internalization has not been described yet in the literature. Even though this study demonstrates the 
possibility of LL-37, LfcinB, BLF and 1018 to enter the cells, further research should be performed 
to evaluate peptide internalization by macropinocytosis or other entry routes.  
Macropinocytosis is a complicated process which involves various cellular factors and 
signaling pathways that influence the dynamics of the actin cytoskeleton needed during all stages of 
macropinocytosis (Fig. 58) (Dharmawardhane, Schurmann et al. 2000; Liberali, Kakkonen et al. 
2008). Small intracellular molecules from Rho GTPases family such as Rac1 and Cdc42 play a 
crucial rule in membrane ruffling. In their activated GTP-bound state they activate several kinases, 
i.e. Pak1 which regulates cytoskeleton dynamics and motility (Dharmawardhane, Schurmann et al. 
2000). Since macropinocytosis stimulation depends on these signaling pathways, external stimuli 
which may trigger some of the signaling pathways, for example cytoskeleton rearrangement, will 
eventually upregulate macropinocytosis. As peptides interact with cell surface glycosaminoglycans 
which are connected to a protein molecule integrated in the plasma membrane and has cytoplasmic 
domain (Fig. 6, Syndecan), this cytoplasmic domain contains regions which are rich in basic 
residues and this regions are believed to be involved in the formation of the cytoplasmic signaling 
complexes. One of the signaling pathway affected by interaction with the cytoplasmic domains of 
syndecans and actin-binding proteins, F-actin, is the change in cytoskeleton organization (Bernfield, 
Gotte et al. 1999). 
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Figure 58. Activation of macropinocytosis through a signaling cascade  (Mercer and Helenius 2009). 
RTK-activated macropinocytosis involves a number of molecules that act as direct or indirect modulators of 
macropinocytic events.  
 In another study, using live-cell confocal analysis, colocalization of the rhodamine labeled 
peptide signals with heparan sulfate on the cell surface has been observed and the actin cytoskeleton 
rearrangement (actin protein fused with the enhanced green fluorescent protein (EGFP) monitored 
by time. Intensive EGFP signals overlapped with the rhodamine signals leading to influx of the 
rhodamine labeled peptide into the cell (Nakase, Hirose et al. 2009). Similar experiments could be 
done in relation to the present study to further elucidate peptide internalization via heparan- and/or 
chondroitin sulfate interaction and to study the possibility of upregulation of macropinocytosis.  
6.4.2 Peptide interference with A-MLV envelope  
 
Another possibility of the observed effect of the peptides in A-MLV internalization that could 
be discussed is the peptide interaction with virus associated heparan- and chondroitin sulfate 
moieties. During virus production, enveloped viruses obtain their envelope during the process of 
budding off from the producer cells. In this way viruses acquire parts of the host cell membrane 
which affects virus-cell interactions (Kolegraff, Bostik et al. 2006). Proteoglycans are widely 
distributed in the plasma membrane and sulfated glycosaminoglycans have been described as part 
of A-MLV envelope and referred to as a virus associated heparan sulfate (Kureishy, Faruque et al. 
2006). In such condition, the role of virus associated glycosaminoglycans in virus attachment to the 
 84 
 
cell surface and the contribution to the viral internalization have been suggested. Virus associated 
heparan sulfate mediates the initial binding of A-MLV to the cells independently of its specific 
envelope protein, gp70 which mediates PiT-2 interaction. The initial binding is mediated by the 
interaction of virus associated heparan sulfate to fibronectin heparin/heparan sulfate binding domain 
(Lei, Bajaj et al. 2002). Fibronectin is  a glycoprotein that is a component of the extracellular matrix 
as well as plasma and is involved in cell adhesion, migration as well as pathogenicity of many 
bacteria and viruses (Influenza virus) (Romberger 1997). Primary attachment to fibronectin is 
followed by further cell specific receptor interaction and cell entry. Even though the exact role of 
fibronectin in viral entry is not well established, studies have suggested that a strong binding to 
extracellular matrix fibronectin is an important step for amphotropic murine leukemia virus entry in 
NIH 3T3 cells (Beer and Pedersen 2007). It has been proposed that this interaction occurs via virus 
associated heparan sulfate, since preincubation of NIH 3T3 cells with heparin weakens A-MLV 
binding (Walker, Pizzato et al. 2002). In addition, Lei et al. showed that gp70 is required for viral 
transduction, but not for binding to fibronectin suggesting that other virus associated surface motifs 
are responsible for the observed interaction such as heparan- and chondroitin sulfate. Moreover, the 
cell membrane associated heparan sulfate is not involved in direct virus-target cell interaction (Lei, 
Bajaj et al. 2002). When bound to fibronectin, A-MLV particles are pretty immobilized and can stay 
in the extracellular matrix for long time before they reach PiT-2 receptors to mediate 
internalization. All in all, fibronectin attachment may be initial and general point of viral attachment 
after which fibronectin-bound viruses interact with more specialized receptors and mediate 
successful internalization. 
 Implementing the above knowledge in the observations in this study, the increased A-MLV 
uptake in presence of the peptides might happen in the following manner. The anionic 
glycosaminoglycans will attract any basic peptides or proteins from the surrounding and upon 
peptide-heparan- and/or chondroitin sulfate binding the fibronectin association will be diminished 
and the virus gp70-PiT-2 interaction will be enhanced leading to faster and more efficient 
internalization. However, peptide binding to virus associated heparan- and chondroitin sulfate 
moieties may happen in various ways, depending on the secondary structure of the peptide and the 
flexibility of the peptide chains upon virus binding and their folding around the viral particle. The 
interaction will also be dependent on the number of sulfated virus associated glycosaminoglycans. 
The overall interference of the peptide on the A-MLV internalization requires more research to be 
done in this area. 
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6.4.3 Peptide interference with the host cell 
 
Polybrene is a soluble polycation widely used to decrease the charge repulsion between the 
viral membranes and the host cells. Counteracting the repulsive electrostatic effects, polybrene 
increases virus-cell adsorption (Davis, Morgan et al. 2002). Even though the precise mechanism of 
action is not well understood, polybrene enhanced A-MLV infectivity in murine fibroblast cells 
(Moneva 2010). Since all of the peptides are cationic species, another possibility of explaining the 
increased A-MLV infection in presence of peptides might be correlated with peptide mimicking 
polybrene behavior.  
 
6.5  Peptides affinities to heparan- and chondroitin sulfate as studied by affinity 
chromatography  
 
Proteins and peptide characterization is still one of the most challenging analytical tasks 
regarding complex biological samples. The difficulty behind protein and peptide analysis comes 
from their structure and therefore often more than one analytical method is applied to obtain 
information for their behavior. In addition, when protein/peptide interactions with various ligands 
are to be characterized things appear even more challenging.  
A classical approach for evaluating the strength of peptide/protein-GAG interaction involves using 
GAG affinity columns which contain GAG units immobilized to either polymer or silica support. 
The sample is loaded onto the media, and eluted with aqueous sodium chloride. The affinity 
determination is reported in terms of sodium chloride concentration needed to elute the peptide. 
Higher sodium chloride concentrations used to elute the peptide indicate tighter binding and in this 
manner binding affinities of many peptides and proteins can be estimated. Heparan sulfate and 
chondroitin sulfate are attached on a stationary phase in the affinity columns and in this 
conformation mimic their native attachment on the cell surface. This is one of the differences when 
one compares affinity chromatography with other analytical methods such as capillary 
electrophoresis and isothermal titration calorimetry. In capillary electrophoresis and isothermal 
titration calorimetry the polyelectrolytes chains are free in solution when mixed with the peptides 
and can therefore fold up around the peptides.  
LL-37, bovine lactoferrin, lactoferricin B,1018 and nisin A eluted at 0.52 M, 0.37 M (0.25 M), 0.31 
M (0.16 M), 0.27 M (0.11 M) and 0.125 M  (0 M) on heparan sulfate column (chondroitin sulfate 
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column elution concentrations are stated in brackets). Propranolol was run only on the chondroitin 
sulfate column and eluted early, before the gradient started (0 M NaCl) (table 5). It should be 
expected that the positive net charge of the peptides should play a crucial role in the affinity binding 
to heparan- and chondroitin sulfate due to the negative charge that both GAGs carry. This can be 
seen for bovine lactoferrin and bovine lactoferricin which carry net charges bigger than 1018 and 
nisin A and exhibit higher affinities. However LL-37 showed higher affinity to heparan sulfate than 
bovine lactoferrin even though LL-37 carries lower net positive charge of +6  in comparison with 
+18 of that of the bovine lactoferrin protein. This is in agreement with the observations from other 
studies where the net positive charge is not the only property of the peptide that governs the affinity 
to GAGs, but the overall composition regarding the secondary structures and the localization of the 
positively charged residues within the structure, matters. Peptide attachment to glycosaminoglycans 
is mediated via electrostatic interactions but specific structural domains in both species are also 
crucial for the interaction. This has been observed in a study where a synthetic peptide analogue 
carrying two extra arginine residues to increase its charge to a same level as lactoferricin B, did not 
show the same affinity to heparan sulfate. The affinity still remained lower than that of lactoferricin 
B, indicating that the position of the charged amino acids is important for the peptides’ ability to 
interact with heparan sulfate (Jenssen, Andersen et al. 2004).  
 The high net charge and two characterized N-terminal domains for glycosaminoglycan 
binding, contribute to the overall lactoferrin binding to heparan sulfate (Mann, Romm et al. 1994; 
Shimazaki, Tazume et al. 1998). Lactoferrin shows affinity for chondroitin sulfate; however the 
affinity is lower when compared with the one for heparan sulfate. This is in agreement with another 
study where the lactoferrin affinities toward heparan- and chondroitin sulfate have been analyzed 
using affinity chromatography (Jenssen, Andersen et al. 2004). Different affinities for chondroitin- 
and heparan sulfate have been observed for the rest of the peptides as well (table 5). This could be 
due to the difference in the overall negative charge and conformational flexibility between heparan- 
and chondroitin sulfate being higher for heparan sulfate (Casu, Choay et al. 1986). Lactoferricin and 
lactoferricin analogues together with short α-helical peptides exhibit high affinity to heparan sulfate 
and this affinity has been shown to be partly due to the peptides net charge (Jenssen, Andersen et al. 
2004-1; Jenssen, Andersen et al. 2004-2). In addition it appeared that when arginine has been 
substituted for lysine in the short peptides the affinity to heparan sulfate has increased (Fromm, 
Hileman et al. 1995; Hileman, Fromm et al. 1998; Jenssen, Andersen et al. 2004-2). In relation to 
peptide antiviral activities based on the affinity studies, a crucial property of lactoferricin peptides 
for exhibiting antiviral activity is the stable secondary structure with internal disulfide bridges 
(Jenssen, Andersen et al. 2004-1).  
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 The importance of disulfide bridges in cysteine has been shown to contribute to the peptide 
interaction with GAG (Heegaard and Kennedy 1999). Lactoferricin is known to fold into 
amphiphatic conformation exposing its positively charged amino acids on the opposite site of the 
cluster of hydrophobic amino acids (Hwang, Zhou et al. 1998).  Similar condensation of charged 
residues has been preserved in synthetically derived short alpha-helical peptides and therefore the 
condensation of charged residues in one side of the peptide surface could favor electrostatic 
interaction with the target molecule giving this structural parameter a general importance (Jenssen, 
Andersen et al. 2004-1; Jenssen, Andersen et al. 2004-2). However, the contribution of the 
arrangement of other amino acids within a peptide structure influence the spatial arrangement of the 
cluster of positively charged residues and therefore it should not be neglected.   
 
6.6  Peptide analysis on capillary electrophoresis 
 
Capillary zone electrophoresis (CZE) method requires small quantities of analyte at relatively 
low concentrations and as an adequate method for peptide/protein analysis is used for establishing 
protein/peptide-ligand complexation constant in the present study. In the method development 
studies for the characterization of different protein/peptides alone, using capillary zone 
electrophoresis, utilization of different buffer systems, pH and ionic strength as well as addition of 
different additives to the running buffer to achieve better separations are applied. However one of 
the main limitations of CZE in proteins and peptides analysis is the adsorption to the capillary wall. 
Silanol groups on the silica fused capillaries act as a cation exchangers, therefore when working at a 
pH where peptides and proteins carry net positive charges (pI > pH), interaction with the capillary 
wall is inevitable (Ermakov, Zhukov et al. 1995). When peptides and proteins are adsorbed to the 
capillary wall, this can change the zeta potential at the capillary wall and influence the 
electroosmotic flow and the capillary efficiency. The consequences of the adsorption phenomena 
are; sample loss that can lead to uncertainty of series of standard concentrations used to obtain a 
calibration curve, decrease in separation efficiency, poor reproducibility of migration times and 
fouled capillaries with peptide/protein sample. All of these effects are as a result of electrostatic 
(Cordova, Gao et al. 1997) and hydrophobic interactions between the peptides/proteins and the 
capillary wall. These effects were observed during the nisin A and lactoferricin B analysis on the 
uncoated silica fused capillary. To overcome such problems, working at low pH that would reduce 
the charge of the capillary wall and therefore reduce electrostatic interactions between 
peptides/proteins and the silanol groups is one of the strategies applied (Szoko 1997; Righetti, Bossi 
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et al. 1999). Secondly, working at pH higher than the pI of the peptides and proteins will introduce 
electrostatic repulsion due to the net negative charges present in the peptides and proteins. However 
these conditions could not be applied to the present study because working in the physiological pH 
is of biological importance, retaining the native structures of the analyte or moreover because direct 
comparison with the biological activity of peptide/proteins and the ligand interactions could be 
deduced. Another strategy is to include various additives in the running buffer, which will compete 
with the basic peptides for the negatively charged capillary wall surface and reduce their adsorption 
(Ermakov, Zhukov et al. 1995; Morand, Blaas et al. 1997; Szoko 1997). Dynamic coating of the 
capillary wall with modifiers that are added to the running buffer is another strategy to decrease 
adsorption. This includes using positively charged polymers that will change the surface of the 
capillary so that highly basic proteins can be separated (Corradini and Cannarsa 1995; Cordova, 
Gao et al. 1997; Chiari and Cretich 2000). The drawback of this approach to reduce the adsorption 
is the limitations of including additives in mixture samples where the additives can interact with the 
sample components; such as chondroitin sulfate in the experiments in this study. The use of 
permanently coated capillaries with neutral, hydrophilic polymers attached to the capillary wall is 
an additional strategy and has been applied in the peptide analysis in this study as well. Three 
neutral capillaries were tried for nisin A and lactoferricin B analysis but due to the limitations of 
their use and stabilities, they did not improve the quality of the measurements.  
Nisin A is a 34 amino acid peptide readily soluble in dilute acids and organic solvent and less 
soluble in water (Cruz, Garden et al. 1996). This solubility issue could be responsible for the 
irregular peaks shape observed in the electropherograms. Thus this corresponds to one of the 
practical consideration in CE-FA, that the solubility in the electrophoresis buffer of species should 
be investigated. Nisin A had been previously analyzed by capillary electrophoresis for separation 
purposes at both low pH and high pH (8.05) in different buffer environments and using uncoated 
silica fused capillary (Cruz, Garden et al. 1996). A number of trace elements could be observed in 
the pure nisin sample which is in agreement with the present observation of the multiple signals in 
nisin A. Increasing the flushing periods between different sample runs and using stronger cleaning 
solutions were applied to avoid such problems. Moreover to reduce the effect of surface adsorption 
of the peptide, the sample was injected from the short end of the capillary, 11 cm to the detection 
window. Also, surface modified capillaries were used in this study; however they did not appear to 
be successful in signal improvements. One should keep in mind that each change in capillaries has 
its own drawback due to the time analysis of differently charged species. 
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The primary objective of the present investigation using capillary electrophoresis was to use the 
developed rapid CE-FA method for assessing complexation of low molecular weight ligand, 
propranolol to chondroitin sulfate in more complicated studies involving highly charged peptides 
such as nisin A, lactoferricin B and bovine lactoferrin protein. Chondroitin sulfate as many other 
negatively charged glycosaminoglycans at physiological pH, interacts with positively charged 
species. The binding curve for propranolol could be reproduced in a satisfactory manner, however 
as more charged peptides were used the more difficult was to establish reasonable curves. 
On the subject of inspecting the charged state of the different plateau observed in nisin A-
chondroitin sulfate complexation experiments, the first signal was shown to correspond to the nisin 
A free concentration. Still it cannot be ruled out that the second plateau can correspond to nisin A-
chondroitin sulfate complex. Such observation has been seen in a study where bovine serum 
albumin protein (BSA) binding to heparin has been investigated. Two plateau signals have been 
seen, where the first one corresponded to the free protein concentrations and the second on to the 
protein-heparin complex (Seyrek, Hattori et al. 2004).  
Regarding the determination of the binding constants, even though there is uncertainty about the 
association constant obtained for nisin A, a quantitative correlation to the binding constant for 
propranolol can be deduced. Propranolol carries one positive charge in contrast to nisin A that 
carries three positive charges at physiological pH. As expected, and in agreement with previous 
studies comparing mono- and dicationic species binding to chondroitin sulfate (Olsen, Chan et al. 
1975), nisin A exhibited higher affinity for chondroitin sulfate than propranolol.  The apparent 
binding constant for nisin A is twice as the binding constant for propranolol, 48.9 M
-1
 and 22 M
-1
,
 
respectively. The early elution of propranolol and nisin A on chondroitin sulfate column in the 
FPLC affinity measurements provides evidence of some consistency between CE-FA and affinity 
chromatography method. Moreover, an additional data that this project could benefit from, could be 
the  inclusion of heparan sulfate in the CE-FA experiments using propranolol and the peptides, so 
that direct comparison with the affinity chromatography results could be made.  
With the experimental conditions applied in the present study only the lower  part of the chondroitin 
sulfate binding isotherm was characterized so the results are not suitable for obtaining information 
about the number of ligand (propranolol/peptides) binding sites per chondroitin sulfate disaccharide 
unit.  
Concerning the difficulties met while sample analysis on the permanently coated capillaries, an 
explanation for such case could be that if the interaction of peptide with chondroitin sulfate gave the 
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complex a net negative charge this would give an overall negative migration time in a capillary 
lacking electroosmotic flow. On the other hand if the complex is neutral than it would not be 
detected at any times. Due to the overall negative migration of peptide and GAG complex, using 
polymer-coated capillary for separation did not appear to be feasible (McKeon and Holland 2004). 
Moreover, injecting a series of samples where the previous components have not been eluted or 
flushed properly in the washing steps, might block or permanently damage the capillary.   
Nevertheless, capillary electrophoresis analysis has been shown to be a good tool in the application 
in structure-function studies elucidated in several studies for peptide-heparin binding where the 
importance of the state of –SH group of Cysteine residue for heparin binding activity had been 
investigated and confirmed that the disulfide structure is important of heparin binding (Heegaard 
and Kennedy 1999) and as such has a great perspectives. 
 
7. Overall discussion and conclusion 
 
Based on the data sets from my biology and chemistry experiments, a direct comparison of 
peptide affinity to heparan- and chondroitin sulfate with the activity they exerted in the viral assays 
can only be done based on the affinity measures from affinity chromatography experiments. 
Capillary electrophoresis experiments did not provide information about the relevant peptide 
affinity to chondroitin sulfate due to the difficulties met during the analysis. This disabled 
establishing direct comparison between the two analytical methods for predicting the affinity 
constants of various peptides from the affinity chromatography studies by simply looking at their 
eluting retention times. The present study establishes macropinocytosis as an entry route of 
amphotropic murine leukemia virus. Moreover, the interference of LL-37, bovine lactoferrin, 
lactoferricin B and 1018 with A-MLV internalization by macropinocytosis is indicated. Even 
though early on a chapter for the mode of antiviral activity of the peptides is given, no antiviral 
activity of the peptide in the viral assays was observed, in contrary all peptides stimulated A-MLV 
uptake in A31 wt cells. However, the understanding of their possible interactions with viral 
envelopes and host cell membrane was implied to speculate their behavioral contribution to the A-
MLV internalization. When the information gathered from the analytical measurements would be 
applied to the observations from the viral assays is difficult to deduce a direct comparison in terms 
of peptide affinity to heparan- and chondroitin sulfate. Even though LL-37 appears to bind the 
strongest to heparan sulfate when compared with bovine lactoferrin, lactoferricin B and 1018, in the 
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viral assay it did not affect A-MLV internalization to a great extend. Whether the peptide 
interference observed is concentration, charge dependent or other structural features play an 
important role remains to be elucidated in further studies. Taking together the observations from the 
affinity chromatography and peptide-viral assays, a table ranking the peptides based on their higher 
affinity to heparan- and chondroitin sulfate and most stimulatory effect on A-MLV internalization 
(Table 8). 
Table 8. Peptide ranking based on affinity chromatography and peptide-viral assay data. 
Peptide HS and CS affinity by 
affinity 
chromatography 
Stimulate A-MLV 
internalization 
LL-37 1 4 
Bovine lactoferrin 
(BLF) 
2 2 
Bovine lactoferricin 
(LfcinB) 
3 3 
1018 4 1 
 
In presence of 1018 peptide the A-MLV internalization is the most enhanced. On the other hand 
1018 exhibits the lowest affinity to heparan- and chondroitin sulfate among the rest of the peptides. 
In contrary LL-37 affinity to heparan- and chondroitin sulfate is the strongest and its interaction 
with A-MLV does not influence A-MLV entry significantly. Peptides that can be successfully 
internalized into the cells are known to be utilized as delivery vehicles for wide variety of 
macromolecular cargos (Cao, Pei et al. 2002; Kaplan, Wadia et al. 2005). Since LL-37 exhibits the 
highest affinity to heparan- and/or chondroitin sulfate moieties on the viral envelope, one might 
speculate that it drags the virus into the cells and aids viral delivery it in the cytoplasm, however in 
wrong compartments leading to partial viral deactivation besides the observed infection degree in 
absence of the peptide. Therefore the A-MLV infection in presence of LL-37 is not significantly 
increased. Taking into account the size of the peptides and their affinity to heparan- and chondroitin 
sulfate, 1018 peptides being the smallest, can surround the viral particle and only bind to 
glycosaminoglycans moieties without space covering the essential viral glycoproteins (gp70) 
important for mediation of specific viral-host cell interactions. In this way the repulsions from the 
negative cells surfaces and negative viral particles will be overcame and the viral particle can get 
faster in contact with its specific receptor to mediate successful internalization. If LL-37 binds to 
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the viral particle it will bind more extensively due to the higher affinity and therefore might cover 
the essential viral glycoprotein, resulting in even possible inhibition of viral entry. However, one 
needs to keep in mind that heparan- and chondroitin sulfate not only are present on the viral 
envelope but on the cell surface as well, so some of the peptides would bind to the virus associated 
moieties whether the rest to the cell surface moieties. Another reason for the difference between the 
1018 and LL-37 effect on A-MLV internalization could be the difference in the internalization 
pathways of the individual peptides. Besides interacting with cell surface proteoglycans, the peptide 
could interacts with other macromolecules present on the cells surface.  
Binding of peptides to glycosaminoglycans on the cell surface and formation of complexes provides 
a solid physiochemical foundation for the involvement of cell surface proteoglycans in peptide 
internalization and signaling which aids viral internalization. In the present study the developed CE-
FA method to study low–molecular weight ligands to the glycosaminoglycan chondroitin sulfate 
was implicated for analyzing high–molecular weight ligands binding to chondroitin sulfate. Even 
though the idea behind CE analysis was to establish affinity constants for the majority of the 
peptides used in the viral assay, a number of technical difficulties were met during the CE analysis 
of peptides-chondroitin sulfate complexation that requires further method development to obtain 
qualitative results. In addition to chondroitin sulfate, once a stable method is developed peptides 
could be analyzed for their affinities to heparan sulfate using capillary electrophoresis. Despite the 
importance of carrying net positive charge at physiological pH, the same exerts analytical problems 
in CE. Peptides separation studies can be performed at low pH values but when one wants to 
observe their behavior in a pH close to the physiological pH, many problems appear which 
challenge modification of normal capillaries and many other modes to ease the analysis.  
In conclusion, this study demonstrates evidence for the amphotropic murine leukemia virus use 
of macropinocytosis for internalization in A31 wt, NIH 3T3 mouse fibroblast cells and HeLa and 
HCT-116, epithelial cells. However other possibilities of alternative routes responsible for A-MLV 
entry are not excluded, taking into account that many viruses use more than one mechanism, i.e. cell 
type dependent, to establish successful infection. Affinity chromatography and capillary 
electrophoresis as analytical tools are rather important in order to establish quantitative peptide 
structure-activity based relationships. However despite the ease of the use of affinity 
chromatography, capillary electrophoresis methodologies require further development. The figure 
below represents a schematic illustration of the possible interference of the peptides with A-MLV 
entry mechanism and gives a brief overview of the content of this project with regards to the results 
and discussion parts which are indicated next to each individual figure/object.   
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8. Perspectives 
 
Even thought the present study manage to accommodate supportive data enabling us to 
conclude on the peptide structure- activity relationships, it generated new hypothesis and ideas that 
needs to be examined in further research.  Such quantitative structure-activity studies could be 
performed in the same fashion employing the viral assays in correlation to the analytical methods, 
affinity chromatography and capillary electrophoresis. In this area, synthetic peptides, a novel 
research tool, could been designed and manipulated in order to avoid some of the limitations that 
native peptides encounter as well as provide the insight into the specific structural requirements for 
the desired in vivo activities.  Additional experiments where peptide derivatives with difference in a 
single amino acid contributing to net charge change, hydrophobicity or any other physiochemical 
change in the structure could be conducted.  
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 Appendix 1 
 
Isothermal titration calorimetry was the third method to be used for determination of peptide- 
glycosaminoglycans binding constants. However, due to limited amount of time and materials only 
few experiments were conducted without much of a success. The principles behind isothermal 
titration calorimetry and some of the results are presented in this section.  
Isothermal Titration Calorimetry  
 
Molecular interactions can be studied with various methods, all contributing to the 
understanding of the nature of the interaction and the affinity of a specific ligand towards a 
substrate. The interactions are dependent on various factors, such as the concentration of the 
molecules, their buffer environment, the kinetics of interaction and the thermodynamic parameters 
associated with the interaction (Ladbury and Chowdhry 1996).The thermodynamic properties of 
such interactions depend on the degree of bonding and types of bonds that are formed between the 
interacting molecules. In the recent years, high sensitivity isothermal titration calorimetry (ITC) has 
been a widely used tool for quantification of thermodynamic properties of many biological 
interactions. Molecular bonding involves breaking and formation of many hydrogen bonds, 
hydrophobic interactions and van der Waals interactions. Such changes either release or require 
heat, and the heat change is what isothermal titration calorimetry detects. This technique allows 
titration of small aliquots of one molecule into another during which time for equilibrium to be 
reached after each injection is allowed From the data obtained from one ITC experiment, one can 
determine the thermodynamic parameters such as the  enthalpy (ΔH), entropy  (ΔS), free energy of 
binding (ΔG), heat capacity (ΔCp), binding constant (Kb) and the effective number of binding sites 
(N) in biological reactions (Ladbury 2001). Most of the parameters describe change in state of a 
system and in general terms, Kb (Kb=1/Kd) and the derived free energy of binding, ΔG, tell us about 
the affinity of an interaction. In addition the enthalpy, ΔH is a direct measure the net heats of bonds 
formation and breaking (Ababou and Ladbury 2007). The parameters are obtained by fitting a 
mathematical expression to the experimental data. When the mathematical expression is based on 
the assumption that the ligand may bind to one type of independent binding sites, the obtained 
fitting parameters are N, Kb and ΔH. Kb is the equilibrium constant for the equilibrium: 
ABBA  , 
 
  BA
AB
K 
                                                                                                                                              
Eq. 11 
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 ,ΔG and ΔS are then obtained from the relation: 
000 ln STHKRTG b                                                                                                   
Eq. 12 
where, R, is the gas constant and T is the absolute temperature. 
 The major advantage of ITC is that there is no great demand in development of a method to study 
specific interaction besides the knowledge of the concentration of the interacting species. Examples 
of types of biological systems that can be studied by ITC include protein-protein/peptide 
interactions (Pierce, Raman et al. 1999), protein-drug (Ward and Holdgate 2001), drug-DNA (Haq 
2002), protein-DNA (Morton and Ladbury 1996) and protein/peptide-glycosaminoglycans (GAG) 
interactions (Fromm, Hileman et al. 1995; Hileman, Jennings et al. 1998; Goncalves, Kitas et al. 
2006). The above mentioned interactions are often characterized by small enthalpy changes, 
however using high sensitivity ITC techniques, it can be measured. Modern instrumentation can 
determine Kb values in the range 10
3
 to 10
9
 M
-1
 (Ladbury and Chowdhry 1996).  
 
Figure 59. Schematic presentation of  ITC instrument (Ladbury and Chowdhry 1996) The instrument 
measures the heat energy per unit time that has to be supplied to the sample cell to maintain thermal 
equilibrium between the two cells.  
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ITC general procedure 
Isothermal titration calorimetry (ITC) measurements and data acquisition relies on the 
differential cell system within the calorimeter assembly. The instrument consists of two identical 
cells (0.5-1.5 ml) placed in an isothermal jacket. The jacket is kept cool, so heat energy is required 
to keep the cells at their constant temperature defined in the experimental set up. The reference cell 
contains water and the sample cell contains either the ligand or the substrate. During titration, 
injection of specific amount (5-25 µl aliquots) of one of the molecules into another is achieved 
through a syringe which has a stirring device at the bottom to allow mixing of the two components 
in the sample cell. Injection of the second component into the sample cell containing the first 
component produces heat effects which are due to stirring, dilution of the ligand, dilution of the 
substrate and the heat of interaction. During ITC experiment both cells are kept at constant 
temperature. After injecting the second component, heat is applied to the system to compensate for 
the heat produced in the sample cell. The applied heat energy as a function of time (µcal s-1) to the 
sample cells, in order to keep the constant temperature in both cells, is directly proportional to the 
heat of reaction (O'Brien R. 2004).  If the reaction is exothermic, less heat per unit time will be 
applied to the sample cell so that the two cells are kept in thermal equilibrium and if the reaction is 
endothermic the opposite situation will be observed (Ladbury and Chowdhry 1996). In a typical 
ITC experiment, the heat absorbed or evolved during a titration process is proportional to the 
fraction of bound ligand, therefore the initial concentrations of both the ligand and the substrate 
should be known. In the beginning of the titration, for the first injection, all or most of the added 
ligand is bound to the substrate resulting in large exo or endothermic signal. 
Over a serious of aliquots of for instance ligand addition, the available interaction sites are being 
saturated so that the heat observed in the last few additions are purely due to the heat of dilution of 
the substrate (Fig. 61A). The heats of dilution of both the reactant can be determined separately, by 
injecting one into a cell containing buffer solution or adding buffer to a cell containing one of the 
components.  
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Figure 60. Sample ITC data. A) Raw ITC data showing exothermic reaction as a result of titration of TAT-
peptide* into heparan sulfate polyelectrolyte at 28
°
 C. Each titration peak corresponds to the injection of 10 
µl of the peptide every 10min. B) Titration plot derived from the integrated raw data from A. The heats of 
reaction as a function of molar ration of TAT-peptide and heparan sulfate. According to a binding model 
derived for this specific interaction, the binding constant is K=5.7±105 M-1 (Ziegler and Seelig 2004).C,D) 
Titration curves in case of strong and weak binding, respectively (Schonbeck, Westh et al. 2010). 
*TAT-peptide represents a fraction of the 47-57a.a residues of the HIV TAT protein. It carries net positive 
charge of +8 at physiological pH. 
 
Experimental procedure and data treatment 
Chondroitin sulfate, propranolol, NisinA and 1018 were diluted in the proper working buffer 
prior to use. The working buffers were phosphate buffer 67 mM, TRIS buffer 10 mM and phosphate 
buffer 50 mM containing 50 mM NaCl. 
The titrations were performed on VP-ITC MicroCalorimeter (Microcal 
TM
) at 25
°
C (40
°
 C for 
propranolol experiments.  For the experiments regarding nisin, the syringe was loaded with the 
peptide or the cationic model compound, propranolol, or chondroitin sulfate.  In all the titration runs 
the volume of the first injection was 2 µl followed by injections of either 5 µ or 10 µl with 300 sec 
interval between each injection. Heats of dilution were measured in a separate titration where the 
chondroitin sulfate was added to a sample cell containing buffer solution. The measured heats of 
dilution were subtracted from the titration heats to yield the heats of interaction. The titration data 
were fitted in a model using Microcals ITC data analysis application for the Origin software 
package. For a complete thermodynamic characterization of the binding isotherms, the data 
obtained from the ITC experiments need to be treated with appropriate binding model. A long 
polymer such as chondroitin sulfate may be described as a macromolecule with n independent and 
equivalent binding site as for ligand such is propranolol, nisin etc. 
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Results 
 
The experiments using ITC take minor part of this experiment due to the limited time used to 
conduct them and the limited amount of working materials. In summary in all of the titration 
experiments, either low signals (Fig. 61) or signals that did not reach saturation point were observed 
(Fig. 62).   
 
Figure 61. Raw data representing titration of chondroitin sulfate (600 µM) in 1018 peptide (100 µM). 
Fast saturation and low signals are observed in this titration.  
 
Figure 62.Isothermal titration calorimetry raw data from titration of 600 µM chondroitin sulfate into 
300 µM nisin A. No saturation is observed.  
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Appendix 2 
Peptide affinity to heparan- and chondroitin sulfate (chromatograms) 
 
 
Figure 63. LL-37 gradient elution on heparan sulfate column by affinity chromatography. The height 
of the peak is used to determine the concentration of sodium chloride needed to elute the peptide. The 
retention time can be also noted.  
 
Figure 64. Chromatogram showing nisin A elution profile on heparan sulfate column. Nisin A elutes 
with 125 mM NaCl at 7.45 min.   
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Appendix 3 
 
Summary of peptide structural properties 
 
Bovine lactoferrin, 1018, LL-37, lactoferricin B and nisin are the peptides used throughout the 
study. Peptide properties are listed in table 9. 
Table 9. List of peptides, their relative molecular weight, amino acid composition and net positive 
charge (positively charged amino acids are shown in red). 
Peptides Mw 
(g/mol) 
Amino acid sequence Number 
of 
amino 
acid 
residues 
Arg 
R 
Lysine 
K 
net+ 
BLF 76145   689     18* 
1018 1537 VRLIVAVRIWRR 12 4   4 
LL-37 4493 LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES 37 5 6 6 
LfcinB 3125 FKCRRWQWRMKKLGAPSITCVRRAF  25 5 3 8 
Nisin 3498 ITSISLC TPGCKTGALM GCNMKTATCH CSIHVSK 34   3 3 
* (Harmsen, Swart et al. 1995) 
**http://www.innovagen.se/custom-peptide-synthesis/peptide-property-calculator/peptide-property-
calculator.asp – website used for calculating of peptide properties based on known structure  
Glossary of terms 
 
Lantibiotics- lanthionine-containing antibiotics, that are highly post-translationally modified 
peptides containing a rare, dimeric amino acid called lanthionine. Due to the presence of these 
dimeric amino acids, the compounds have multiple ring structures. 
(http://www.novactabio.com/page.php?id=34 ) 
Junin virus- enveloped, ssRNA virus that causes hemorrhagic fever.  
http://www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/junin-eng.php  
Polyomavirus- non-enveloped viruses, ~45nm in diameter. Polyomavirus genomes are d/s, circular 
DNA molecules, ~5kbp in size. Viruses that belong to this group are: BK Virus (BKV), JC John 
Cunningham Virus (JCV) and simian virus 40 (SV40). 
http://www.microbiologybytes.com/virology/Polyomaviruses.html  
 
Consensus sequence- a sequence of nucleotides or amino acids similar or identical between regions 
of homology in different but related DNA, RNA, or protein sequence. 
 http://medical-dictionary.thefreedictionary.com/consensus+sequence  
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